Attack of the clones

Is FDA Promoting or Regulating Cloned Meat and Milk?

Dr. Mae-Wan Ho and Prof. Joe Cummins find cloned meat and milk unethical and unsafe.

(This article has been submitted to the FDA. Please circulate widely to your elected representatives)

US Food and Drug Administration (FDA) is about to approve cloned meat and milk for the market. But a large coalition of civil society organizations is opposing the decision on both safety and ethical grounds [1]. The coalition is led by the Center for Food Safety based in Washington DC, and includes the Humane Society with nearly 10 million members, and the Consumer Federation of America with membership of more than 50 million.

A recent poll commissioned by the International Food Information Council (a non-profit organization supported by the food, beverage and agricultural industries) found nearly 60 percent of respondents would not touch products from cloned animals with only 9 percent “very likely” to buy them. This compares with 40 percent who would not buy genetically modified animal products.

Misleading ‘risk assessment' by FDA and cloning companies

In preparation for FDA's approval of cloned animal products, the agency published a ‘commentary' in the January 2007 issue of Nature biotechnology [3] supported by a ‘perspective' piece on risk assessment, co-authored by scientists from at least two cloning companies [4]. Both papers put the same misleading positive gloss on cloned animals. The FDA paper explains why cloned meat and milk are as safe as the conventional products, because “there are no unique risks associated with animal cloning,” while the risk assessment commentary cites the FDA paper in agreement. Neither paper considers ethics or animal welfare.

Both papers present somatic cell nuclear transfer cloning (SCNT) reassuringly as the latest development in a “continuum” of artificial insemination, multiple ovulation/embryo transfer, in vitro fertilization, embryo cryopreservation, cloning by embryo splitting, and since the 1980s, by embryonic cell nuclear transfer (ECNT).

First of all, it is highly misleading to pretend that clones obtained by nuclear transfer are the same as clones obtained by embryo splitting. The latter is typically done at the 2-4 cell stage, and is not so different from the twins or multiplets that happen naturally from time to time.

Nuclear transfer cloning involves introducing the nuclei of embryonic cells (in ECNT) or adult somatic cells (in SCNT) into unfertilised eggs that has had the egg nucleus removed. The reconstituted eggs are then activated to develop, and the resultant embryos are implanted into surrogate mothers hormonally synchronized to receive them. Nuclear transfer cloning, especially SCNT results in extremely high failure rates from deaths and gross abnormalities, so much so that scientists speak of a “cloning syndrome” that arises from errors in epigenetic programming of the cell nucleus [5, 6]. The individual symptom may not be unique, but the combination and the high incidences of the symptoms certainly constitute a unique syndrome. It inflicts massive deaths, suffering and distress, not only to the cloned foetuses and the calves throughout gestation, at and after birth, but also to the surrogate mothers [7]. Surrogate mothers frequently die from difficult delivery unless medical intervention is given, and their health is seriously compromised by gross malformations of the foetuses.

******

Admittedly, many deaths and gross abnormalities occur in animal cloning, but the companies claim that those clones born alive and survive the perinatal period are healthy [4]. To support their case, they tabulate nine studies, eight published elsewhere and one described in their paper, showing that the milk and meat products from clones are indistinguishable from controls, according to compositional studies on proteins, fats, somatic cell count, amino acid composition, vitamins, minerals etc, as recommended by the FDA [3].

Had the FDA recommended more discerning tests similar to those now routinely used in the laboratory for DNA, RNA, protein and metabolic profiling, large numbers of differences would have been detected, as SCNT clones are notorious for epigenetic errors that result in major changes in DNA markings, RNA and proteins expressed (see below), and it would be surprising if these did not result in metabolic differences.

******

By any standards, these data are grossly inadequate to establish the safety of cloned meat and milk or any other cloned animal products. They are also fundamentally flawed, as single parameters are compared, rather than an entire pattern, so when differences did occur between the cloned and non-cloned siblings, they were dismissed by the comment that the values were within the normal range typical of the breed or species.

Nanoalimentos

Alert: Nanotechnology Food Coming to a Fridge Near You

* By Cathy Garber
Nanowerk LLC - Honolulu, HI, Jan 30, 2007

(Nanowerk Spotlight) The potential benefits of Nanofoods­ - foods produced using nanotechnology - are astonishing. Advocates of the technology promise improved food processing, packaging and safety; enhanced flavor and nutrition; 'functional foods' where everyday foods carry medicines and supplements, and increased production and cost-effectiveness. In a world where thousands of people starve each day, increased production alone is enough to warrant worldwide support. For the past few years, the food industry has been investing millions of dollars in nanotechnology research and development. Some of the world's largest food manufacturers, including Nestle, Altria, H.J. Heinz and Unilever, are blazing the trail, while hundreds of smaller companies follow their lead.

Examples for nanofood applications (Source: Nanowerk)

Yet, despite the potential benefits, compared with other nanotechnology arenas, nanofoods don't get a lot of publicity. The ongoing debate over nanofood safety and regulations has slowed the introduction of nanofood products, but research and development continue to thrive - though, interestingly, most of the larger companies are keeping their activities quiet (when you search for the term 'nano' or nanotechnology' on the websites of Kraft, Nestle, Heinz and Altria you get exactly zero results). Although the risks associated with nanotechnology in other areas, such as cosmetics and medicine, are equally blurry, it seems the difference is that the public is far less apt to jump on the nanotechnology bandwagon when it comes to their food supply. According to a definition in a recent report (Nanotechnology in Agriculture and Food) food is "nanofood" when nanoparticles, nanotechnology techniques or tools are used during cultivation, production, processing, or packaging of the food. It does not mean atomically modified food or food produced by nanomachines.

READ THE REST

La verdad acerca del Bt

BT COTTON -- THE FACTS BEHIND THE HYPE

by GRAIN

http://www.grain.org/seedling/?id=457

It has been over ten years now since genetically modified Bt cotton was first commercialised. Since then it has been introduced or tested in more than twenty countries. The crop is a clear success for Monsanto, the leading Bt cotton company. But what has it meant for farmers? Today, a more complete picture is finally emerging of what is happening on the farm in many countries throughout the world.

Smallpox

WHO Board Urged to Act on Worrying Smallpox Research Trends

The issue of destruction of smallpox virus stocks has been heatedly discussed at the World Health Assembly (WHA) for several years, particularly following recommendations from a WHO advisory committee in 2004 to greatly expand dangerous smallpox research, including genetic engineering experiments.

The 2006 WHA was unable to agree upon the text of a resolution on destruction of variola virus stocks, which are held in WHO authorized repositories in the US and Russia. Many developing countries, led by Africa, sought a resolution that established a destruction date for the virus (in June 2010), a prohibition on genetic engineering, annual substantive WHA review of virus research, and strengthened WHO oversight. The US refusal to consider fixing a new destruction date was problematic, and developing county offers of a compromise were also rejected. As a result, the WHO Executive Board is considering the draft resolution as it meets from 22-30 January 2007. NGOs are urging the Board to produce a strong resolution, given increasing indications that the US is expanding or intending to expand research with the smallpox virus and with smallpox genes.

The Oakland Institute's Senior Fellow Lim Li Ching reports...

Editorial de GRAIN

New from GRAIN
January 2007
www.grain.org/nfg/?id=466


The latest issue of Seedling is now available at:
http://www.grain.org/seedling/?type=66

And two photo essays are available (details below):
http://www.grain.org/pe/


IN THIS SEEDLING ISSUE...

Every day the biotechnology companies bombard us with their publicity. We are told that eight million farmers throughout the world are already enjoying higher yields and lower production costs because of the benefits of genetically modified crops. And forever dangled before us is the carrot of far greater improvements in the future. We are promised that within a decade the biotech companies will have designed crops that will deal with drought, salinisation and all the other problems that we are likely to be facing as the result of global warming and climate change.

But how true are these claims? Have hybrids and GM crops really reduced costs and increased yields? And is this kind of farming sustainable? It is often difficult to probe behind the hype of the biotech companies and to find out what is happening on the ground. In this edition, we have an extensive first-hand report from China about the real impact of hybrid rice, which now covers well over half of the area under rice cultivation in this vast country. Another article brings together reports from many different countries -- Burkina Faso, China, India, Indonesia, South Africa and the USA -- about the impact of Monsanto's genetically modified Bt cotton, which has now been on the market for a decade. The reports uncover profound concerns among the farmers and a worrying lack of transparency among the advocates of the new technologies. In both cases, it is clear that, even if the new crops bring short-term benefits (and this is not always the case), these can soon be outweighed by serious long-term problems in both the financial and agronomic viability of the new varieties.

The biotech companies' response to the plethora of problems is to come up with another round of technical fixes. We are already hearing about the second -- and even third -- generation of GM crops engineered to deal with the problems created by the first generation. And so it will continue.? Not surprisingly, many farmers throughout the world are increasingly sceptical and are returning to the tried-and-tested practices of agro-ecological farming. Support is growing for the concept of food sovereignty -- the idea that communities have the right to define their own agricultural, pastoral, labour, fishing, food and land policies, in accordance with their own ecological, social, economic and cultural circumstances.

In this edition, we talk to two different proponents of food sovereignty, one in Africa, one in India. Not surprisingly, their strategies are different, for they come from very different parts of the world, but they agree on one essential point -- the need for local farmers to be the ones who decide which crops they cultivate, what farming methods they use and how their produce should be marketed. In February advocates of food sovereignty from the five continents will be meeting in Mali for the Forum for Food Sovereignty.

We are planning in 2007 a special issue on biofuels, the new craze that is sweeping through the world. The biotechnology companies are moving quickly to produce genetically modified crops especially tailored for the manufacture of ethanol and other biofuels. We would like to receive any comments or information that you, the readers, have on this topic. We plan to publish a list of the ten most useful documents on biofuels, and would welcome suggestions.

Effect of genetically modified crops on developing countries

HULIQ, NC, 26 January 2007

http://www.huliq.com/8118/effect-of-genetically
-modified-crops-on-developing-countries

A new study in the February issue of Current Anthropology explores how the arrival of genetically modified crops affects farmers in developing countries. Glenn Davis Stone (Washington University) studied the Warangal District of Andhra Pradesh in India, a key cotton growing area notorious for suicides by cotton farmers.

In 2003 to 2005, market share of "Bt cotton" seeds rose from 12 percent to 62 percent in Warangal. Bt cotton is genetically modified to produce its own insecticide and has been claimed by its manufacturer as the fastest-adopted agricultural technology in history.

Monsato, the firm behind Bt cotton, has interpreted the rapid spread of the modified strain as the result of farmer experimentation and management skill – similar to mechanisms that scholars cite to explain the spread of hybrid corn across American farms. But Stone's multiyear ethnography of Warangal cotton farmers shows an unexpected pattern of localized cotton seed fads in the district. He argues that, rather than a case of careful assessment and adoption, Warangal is plagued by a severe breakdown of the "skilling" process by which farmers normally hone their management practices.

"Warangal cotton farming offers a case study in 'agricultural deskilling'," writes Stone. The seed fads had virtually no environmental basis, and farmers generally lacked recognition of what was actually being planted, a striking contrast to highly strategic seed selection processes in areas where technological change is learned and gradual. Interviews also provided consistent evidence that Warangal cotton farmers prefer trying new seeds – seeds without any background information whatsoever – to trying several strains on smaller, experimental scales and choosing one for long-term adoption.

The problem preceded Bt cotton, Stone points out; its root causes are reliance on hybrid seed, which must be repurchased every year, and a chaotic seed market in which products come and go at a furious pace and farmers often cannot tell what they are using. Farmer desire for novelty exacerbates the turnover of seeds in the market, Stone argues, and seed firms will frequently take seeds that have fallen out of favor, rename them, and resell with new marketing campaigns. For instance, one recent favorite seed in several villages is identical to four other seeds on the market.

Stone argues that the previously undocumented pattern of fads, in which each village lurches from seed to seed, reflects a breakdown of the process of "environmental learning," leaving farmers to rely purely on "social learning." Bt cotton was not the cause of this "deskilling," but in Warangal it has exacerbated the problem.

"On the surface, [Warangal] appears to be a dramatic case of successful adoption of an innovation," Stone explains. "However, a closer analysis of the dynamics of adoption shows that the pattern some see as an environmentally based change in agricultural practice actually continues the established pattern of socially driven fads arising in the virtual absence of environmental learning."

Strangely, in another part of India, a very different history of Bt cotton has led to an improvement in agricultural skilling. In Gujarat, the loss of corporate control over the Bt technology has led to an increased involvement of farmers in local breeding, and an apparent increase in knowledge-based innovation. - University of Chicago Press Journals

Mala leche

WHAT'S IN YOUR MILK?

An Expose of Industry and Government Cover-Up on the DANGERS of the Genetically Engineered (rBGH) Milk You're Drinking

http://www.world-wire.com/news/0701030001.html

FOR IMMEDIATE RELEASE

CHICAGO, Illinois, January 3, 2007 --/WORLD-WIRE/-- Dr. Samuel S. Epstein, professor emeritus of environmental medicine at the University of Illinois at Chicago School of Public Health and world renowned author, has announced the publication of his new book, "What's in Your Milk?", a powerful expose of the dangers of Monsanto's genetically engineered (rBGH) milk, and the company's no-holds-barred conspiracy to suppress this information.

rBGH (recombinant Bovine Growth Hormone) is a genetically engineered, potent variant of the natural growth hormone produced by cows. Manufactured by Monsanto, it is sold to dairy farmers under the trade name POSILAC. Injection of this hormone forces cows to increase their milk production by about 10%. Monsanto has stated that about one third of dairy cows are in herds where the hormone is used.

Monsanto, supported by the Food and Drug Administration (FDA), insist that rBGH milk is indistinguishable from natural milk, and that it is safe for consumers. This is blatantly false:

rBGH makes cows sick. Monsanto has been forced to admit to about 20 toxic effects, including mastitis, on its Posilac label.

*rBGH milk is contaminated by pus, due to the mastitis commonly induced by rBGH, and antibiotics used to treat the mastitis.

*rBGH milk is chemically, and nutritionally different than natural milk.

*Milk from cows injected with rBGH is contaminated with the hormone, traces of which are absorbed through the gut into the blood.

*rBGH milk is supercharged with high levels of a natural growth factor (IGF-1), which is readily absorbed through the gut.

*Excess levels of IGF-1 have been incriminated as a cause of breast, colon, and prostate cancers.

IGF-1 blocks natural defense mechanisms against early submicroscopic cancers.

*rBGH factory farms pose a major threat to the viability of small dairy farms.

*rBGH enriches Monsanto, while posing dangers, without any benefits, to consumers, especially in view of the current national surplus of milk.

Of still greater concern, based on 37 published scientific studies as detailed in the book, excess levels of IGF-1 in rBGH milk pose major risks of breast, colon and prostate cancers.

The introduction to What's in Your Milk? by Ben Cohen, Co-founder of Ben & Jerry’s Ice Cream, with a Foreword by Jeffrey M. Smith, author of the bestseller Seeds of Deception

Many prominent experts in the environmental field have endorsed the new book including Congressman John Conyers, Jr., Ranking Democrat, House Judiciary Committee, Mark Achbar, Executive Producer of the multiple prize-winning documentary The Corporation, Ronnie Cummins, National Director, Organic Consumers Association, and Dr. Joseph Mercola, founder of the world’s most visited natural health website.

The book is a unique resource on rBGH milk. It presents Dr. Epstein's trailblazing scientific publications since 1989, which have played a major role in influencing other nations, including Canada, 24 European nations, Norway, Switzerland, Australia, New Zealand, and Japan to ban rBGH milk. The book also presents: the author’s editorials and letters to major newspapers, and correspondence with the FDA, Congressman John Conyers, and other key members of Congress and the Senate. Epstein also details evidence of interlocking conflicts of interest between Monsanto and the White House, the American Medical Association and American Cancer Society. He also details evidence of Monsanto's white collar crime; the suppression and manipulation of information on the veterinary and public health dangers of rBGH milk; and evidence of Monsanto's "Hit Squad," which attempted to stifle and discredit him.

Of compelling interest is the story behind Fox Television's firing of Jane Akre, a veteran journalist, following her in-depth interview on rBGH with Dr. Epstein, his subsequent day-long deposition by Monsanto on her behalf, her subsequent litigation against Fox, and Fox's successful counter suit.

Monsanto's corporate recklessness, compounded by FDA's complicity and refusal to require labeling of rBGH milk, more than justify the rejection of any assurances of its safety. Of further interest is the critical relevance of this information to the ongoing growing concerns and debate on genetically engineered foods, including irrefutable evidence discrediting the "trust us" safety assurances of Monsanto, and other industries.

The book also presents resource materials, including listings of national and international anti-biotech, public health, veterinary and animal rights activist groups. Also listed are rBGH-free U.S. dairy producers, such as Horizon Organic, and Swiss Valley Farms.

What's In Your Milk’s critical message to consumers is, BOYCOTT rBGH HORMONAL MILK IN FAVOR OF CERTIFIED ORGANIC MILK.

The book is available from Trafford Publishing, www.trafford.com/06-0676, or by calling Trafford’s Order Desk at 888-232-4444 or 250-383-6864, and subsequently at amazon.com and major bookstores everywhere. Cost of "What's in Your Milk" is $24.95 USD For overseas orders, contact national Amazon sites or other major bookstores and on-line retailers. GBP14.35 GPB, 20.49 Euros Dr. Epstein is professor emeritus of environmental medicine at the University of Illinois at Chicago School of Public Health, and Chairman of the international Cancer Prevention Coalition. He is the author of 270 scientific publications, and author or co-author of 12 books, including the prize winning 1978 The Politics of Cancer, the 1995 The Safe Shopper's Bible, and the 2005 Cancer-Gate: How to Win the Losing Cancer War.

Dr. Epstein has been the recipient of many awards, including the 1998 Right Livelihood Award, the Alternative Nobel Prize, for his "incomparable contributions to cancer prevention, and for his leadership role in warning of the dangers of rBGH milk." Dr. Epstein has also received the the 2000 Project Censored Award. In 2005, Dr. Epstein was awarded the Albert Schweitzer Golden Grand Medal "for Humanitarianism, and International Contributions to Cancer Prevention."

Visit the Cancer Prevention Coalition: http://www.preventcancer.com

For more information contact:
Samuel S. Epstein, M.D.
Chairman, Cancer Prevention Coalition
(312) 996 2297
Chicago, Illinois

GM crop picture not as rosy as industry claims

Biowatch South Africa Press statement, 24 January 2007

Industry-funded International Service for the Acquisition of Agri-biotech Applications (ISAAA) claims of increases in the growing of genetically modified (GM) crops and overwhelming acceptance of this risky new technology is flawed.

Statistics from ISAAA have been exaggerated in the past, according to a report released this month by Greenpeace International.

ISAAA claimed that in 2005 Romania grew 125000 hectares of GM soy, while the Romanian government put the area at only 87000 hectares. In 2006, ISAAA claimed that Iran was growing GM crops commercially, although Iran is neither growing nor has it approved any GM crops on a commercial scale.

According to ISAAA, of the 25 European Union states six are growing GM crops. It is silent on the banning on cultivation of GM soy by Romania, the ban on GM maize by Austria and that seven European countries have banned one or more GM crops.

According to ISAAA, China has 3.5 million hectares under GM crop cultivation. Nevertheless, Kraft Foods, the world’s second largest food producer, has committed itself to supply China with GM-free food from January 1 2007. The Chinese government’s biosafety committee has also called for more data and assessment about the safety of GM rice, so delaying a decision on its commercial approval for at least a year.

Following the discovery in 2006 that significant quantities of USA long grain rice were contaminated with an unapproved GM variety, the Rice Producers of California and a major rice mill in the state have called for a ban on the growing of GM rice, including in field trials. The world's largest rice processor, Ebro Puleva, has also committed to being GM-free and rice traders in Thailand and Vietnam, the world's two largest rice exporting countries, have done the same.

In India, which ISAAA says is the leading GM crop grower in Asia, the Supreme Court has placed a temporary ban on all field trials of GM crops.

ISAAA claims Brazil has 11.5 million hectares under GM crop cultivation but Brazil continues to resist GM industry attempts to get approval for GM maize.

Even in South Africa, where ISAAA says there has been a 180% increase in the area under GM crop cultivation, the regulatory authority for GM applications last year rejected an application for experiments with GM sorghum - because they feared contamination of local sorghum varieties. And towards the end of 2006, the South African Wine Industry Council objected to an application for the use of GM yeast in winemaking.

Research in South Africa and worldwide is showing that GM crops have none of the benefits which the GM industry persistently promises.

A joint seven-year study by Chinese and United States researchers found that Chinese farmers growing GM cotton lost money. The researchers, from the Centre for Chinese Agricultural Policy, the Chinese Academy of Sciences and Cornell University in the United States, found that farmers who had planted Bt cotton initially cut their pesticide use by more than 70% and had earnings 36% higher than those planting conventional cotton. But after that, the farmers growing Bt cotton had to spray as much pesticide as farmers growing conventional cotton. This resulted in them earning 8% less than conventional farmers because the Bt cotton seed was triple the cost of conventional cotton seed. After seven years, other insects had increased so much that the farmers growing Bt cotton were having to spray their crops up to 20 times per growing season.

A study of GM cotton farmers in Makhathini Flats in KwaZulu Natal by University of KwaZulu Natal researchers, found that cotton yields in the area were more or less the same before and after the adoption of GM cotton. Based on their discussions with those familiar with pesticide application in the area, the researchers suggested a similar scenario with pesticide use as was the case in China.

For more information, queries, please ring Leslie Liddell, Biowatch South Africa director, on 021-447 5939 or 073 307 8873

TAINTING AFRICA'S HERITAGE

TAINTING AFRICA'S HERITAGE:
WAMBUGU, GATES FOUNDATION AND DUPONT'S GM SORGHUM PROJECT

A Briefing Paper by THE AFRICAN CENTRE FOR BIOSAFETY

10 JANUARY 2007

BACKGROUND

On the 15 June 2006, the Executive Council (EC), a statutory body established by the Genetically Modified Organisms Act comprising six government departments (science and technology, agriculture, trade and industry, health, labour, and environmental affairs and tourism) turned down the Council for Scientific and Industrial Research's (CSIR) application to conduct laboratory and greenhouse experiments on genetically modified (GM) sorghum. This decision was taken against the backdrop that Africa is the centre of origin for sorghum where (including in South Africa) a large number of sexually compatible weeds, wild relatives strains and races of cultivated sorghum occur. In this regard, the EC cited concerns regarding the risks "pertaining to possible impact as a result of gene flow on bio-diversity".[1]

The EC specifically requested that the CSIR characterise sorghum species in South Africa with particular regard to examining sexual compatibility, geographic distribution, climatic requirements and importance to bio-diversity, including nutritional characterisation of the different species of sorghum in S.A.

Derek Hanekom, the deputy science and technology minister said in August 2006 that the South African government might well reconsider its stance if the CSIR could demonstrate to the council that the sorghum is suitably contained.[2] In September 2006, an application was re-submitted in the name of the CSIR Biosciences to conduct an assessment of GM sorghum that has been engineered to express a high-lysine storage protein from barley.[3]

This new application provides for the use of a level 3 containment facility. Upon examination by the ACB, not only does the application fail to address the various concerns raised by the EC, we have found it to be extremely sketchy and based on wholly inadequate, erroneous and unsubstantiated scientific information. It appears as if the aim of the application is to forge ahead with the GM sorghum experimentation at all costs, including the wholesale contamination of Africa’s prized sorghum heritage.

Wambugu, Bill and Melinda Gates Foundation, and Dupont's Role in the Development of GE Sorghum

Florence Wambugu, well known for the disastrous GM sweet potato project in Kenya, sits on the Science Board of the Grand Challenges in Global Health, the initiative created by the Bill and Melissa Gates Foundation (BMGF).[4] Wambugu's African Harvest Foundation, in collaboration with DuPont Crop Genetics Research (Pioneer HiBred International) has been granted $16.9 million by the BMGF to conduct research on Nutritionally-Enhanced Sorghum for the Arid and Semi-Arid Tropical Areas of Africa.This project has been given the moniker, the Africa Biofortified Sorghum (ABS) Project. Already under this grant, in partnership with the CSIR in South Africa, a genetically engineered new variety of sorghum containing increased levels of the amino acid lysine has been produced.[5] The stated aim of the ABS Project is to "develop sorghum with improved food quality by enriching it for essential amino acids (part of the protein component of the diet), and later by increasing its content in essential vitamins (vitamin A and E)"[6] and to do so by the application of genetic modification. The outcome of this project would be the development of a Super Sorghum.6

Still knocking on a closed door….

Despite successful litigation by South African based NGO, Biowatch South Africa regarding the public's right to information regarding GM regulation and risk assessment data, the public continues to be denied vital information to conduct a proper assessment, including such basic information as the molecular description and characterisation information. The ACB has not been able to make a full and complete assessment of the application since the bulk of the pertinent information is contained in Annexures, copies of which were denied to us. The engagement by the public with the applicant needs to be made on the basis of complete and accurate information being made to it and in accordance with the court order made in the Biowatch litigation.

Contamination of Africa's wild relatives of Sorghum

Nevertheless, what the applicants could not hide from public scrutiny is that they are unable to provide any references to scientific peer reviewed journals of the various safety claims they make regarding the impacts of their GM sorghum on the biosystem. Indeed, the applicants state that the opportunities for out-crossing to cultivated sorghum and to wild relatives of sorghum are highly unlikely (page 2) because of the level 3 containment facility that is proposed for the release.

The distinct impression gained from the application is that s impacts of the release of the transgene are negligible - a view not supported by the published literature.

During February 2005 Schmidt and Bothma reported on a crop-to-crop gene flow risk assessment study conducted in South Africa, with Sorghum bicolor subsp. bicolor to estimate the impact of transgenic sorghum in (South) Africa.[7] This study was funded by the Agricultural Research Council at which Bothma is employed. The field trial was conducted at on the 4000-ha ARC research farm Roodeplaat close to Pretoria. A central sorghum field (30 x 30 m) was planted with male fertile donor plants and surrounded by eight arms planted with male sterile recipient plants at a distance of 13 to 158 m from the central field. Gene flow was found to be high within the first 40m and whilst low beyond this point, regardless gene flow was detected even at the 158 m point.[8]

In South Africa we have the presence of fully fertile crop wild relatives and the weedy relative johnsongrass [S. halepense (L.) Pers.], which may form hybrids with crop sorghum. Johnson grass is classified as one of the world's most noxious weeds.

The authors concluded that the fact that gene flow takes place and the presence of these weedy and wild relatives provides strong evidence that introgression of genetically modified-(GM)-sorghum into crops and crop wild relatives will take place once GM sorghum is deployed.

CONCLUSION

The South African Sorghum gene flow study raised very serious concerns of introgression of GE-sorghum into wild relatives. The South African government is obliged in terms of its national and international obligations under pertinent multilateral environmental agreements such as the Cartagena Protocol on Biosafety, to protect biodiversity, refuse the application. Some activities just cannot be permitted and should be regarded as NO GO options, such as the release of GM sorghum into greenhouses. The risks posed by GM sorghum to sorghum wild and weedy relatives cannot be tolerated at all and the granting of a permit will be tantamount to a licence to taint Africa's heritage.

Ultimately, Wambugu et al's ABS project is being developed for commercial release and will have to undergo field trials. If the original objection of the EC made on 15 June 2006 was based on concerns regarding containment and possible adverse effects on local varieties, any further development or re-consideration of the application must be forestalled by this very concern itself. Containment now in a level 3 containment facility will not negate these concerns for field trials and the risks to local varieties will remain.

--------------------------------------------------------------------------------

[1] Hanekom, D. (2006) Cautiously sowing the seeds of change. 2 August. Business Day.

[2 http://www.businessday.co.za/articles/topstories.aspx?ID=BD4A243447

[3]CSIR Biosciences. Application for Contained use of Genetically Modified Organisms (GMOs) in South Africa. Africa Bio-fortified Sorghum (ABS) Project. 17/3/1-CSIR-06/005. non-CBI

[4]Grand Challenges in Global Health. Scientific Board. http://www.grandchallengesgh.org/board.aspx?SecID=260

[5]Grand Challenges in Global Health. Nutrient-Rich Plants. http://www.gcgh.org/subcontent.aspx?SecID=390

[6]SuperSorghum.org. The ABS Consortium. The Project. http://supersorghum.org/project.htm

[7] Schmidt, M. & Bothma, G. (2006) Risk Assessment for Transgenic Sorghum in Africa: Crop-to-Crop Gene Flow in Sorghum bicolor (L.) Moench. Crop Sci. 46:790–798

[8] Ibid

Maíz y mentiras de fondo

La Jornada, México, 20 de enero 2007

Maíz y mentiras de fondo

Silvia Ribeiro*

Es patética la cantidad de falsedades que desde autoridades a empresarios agropecuarios y empresas trasnacionales nos lanzan a la cara sobre el alza vertiginoso del precio de la tortilla y sus posibles soluciones. Unos para justificarse, otros para ver que más pueden ganar. ¿Qué se puede decir cuando los mismos que producen el alza artificial de precios del maíz, a través de la especulación y el acaparamiento, como por ejemplo la trasnacional Cargill, se sientan con el gobierno y "avalan" que el aumento de la tortilla sea "solamente" de 40%?

¿O que el gobierno anuncie como paliativo que ahora se exceptuarán de arancel de importación a 2 millones 850 mil toneladas de maíz, cuando desde la firma del Tratado de Libre Comercio de América del Norte (TLCAN) nunca se han cobrado los aranceles de importación al maíz que México tenía derecho a cobrar según el propio tratado? Se han importado desde entonces entre 5 y 8 millones de toneladas anuales libres de arancel, una inmensa sangría al erario de la que se han beneficiado las grandes empresas de distribución de cereales como Cargill y Archer Daniel Midland, y los grandes industriales que usan el grano para harina y forrajes, como Maseca, Minsa, Bachoco, Pilgrim's Pride, Tyson.

Este flujo de importación no solamente compitió deslealmente con la producción nacional, sino que además causó la impune contaminación transgénica del maíz campesino, dañando uno de los mayores acervos económicos, culturales e históricos del país y del mundo. Es grave que la distribuidora pública Diconsa -- que por la enorme capilaridad para llegar a las poblaciones campesinas a través de sus más de 22 mil tiendas rurales fue identificado como unas de las principales fuentes de contaminación transgénica-- anuncie que romperá su ya insuficiente compromiso de 2003 de comprar maíz solamente a productores nacionales y que volverá a importar.

Pero aún más cínico en medio de tanta falacia es que las trasnacionales de los transgénicos aprovechen para decir que el maíz transgénico sería la solución "de fondo" para aumentar la producción de maíz en México. Afirmación totalmente arbitraria, ya que el maíz transgénico produce igual o menos que el convencional según múltiples datos oficiales de Estados Unidos, el mayor productor mundial de maíz y de transgénicos.

En esta ocasión la letanía sale como declaración del Consejo Nacional Agropecuario (CNA), asociación integrada por los grandes productores agropecuarios y agroindustriales de México junto a las megaempresas nacionales y trasnacionales relacionados con los agronegocios. No es extraño, cuando entre sus asociados están Monsanto, Syngenta y Agrobio México (que agrupa a las trasnacionales de agrotransgénicos), además de Cargill, Grupo Minsa, Bachoco, Pilgrim's Pride, Tyson.

Entre los logros históricos en los que el CNA se adjudica "participación activa", están la modificación del artículo 27 (que abrió la puerta para el proceso de privatización de las tierras ejidales y comunales); la firma de TLCAN y la desregulación de la Secretaría de Agricultura. Ahora quieren agregar a esta impresionante lista de devastación, la presión para lograr la siembra de maíz transgénico en México, su centro de origen.

Lo que ocultan las declaraciones de estos (no tan) nuevos señores feudales del campo mexicano es que nada menos que el 85 por ciento de los productores de maíz en México son campesinos, cultivan en predios de menos de cinco hectáreas y no dependen de ellos. Manejan una enorme diversidad de semillas adaptadas durante siglos a diferentes climas y geografías, lo que, al contrario de las semillas uniformes industriales, son útiles en las condiciones marginales donde los conquistadores y anteriores señores feudales los empujaron a vivir, primero a sangre y fuego y más tarde a punta de urbanización salvaje y otros despojos.
Estos tercos y dignos campesinos y campesinas indígenas que son los creadores de las semillas --con las que especulan ahora los dueños del dinero-- siguen usando mayoritariamente sus propias semillas, base de su alimentación y autonomía. La introducción legal y masiva de transgénicos los condenará a la contaminación, a juicios por "uso ilegal de genes patentados" y más tarde a la bioesclavitud de comprar semillas a las trasnacionales cada año. Finalmente, a desaparecer como campesinos en la competencia con la avalancha de maíz industrial y la batería de políticas anti-campesinas y anti-indígenas, condenándolos, como al resto de la población, a consumir tortillas de maíz transgénico; harinizado, no nixtamalizado; de mala calidad, con menor valor nutritivo y riesgos para la salud.

Si el problema que vivimos fuera de volumen de producción (un punto a debatir, ya que la producción actual de maíz es suficiente e incluso excedentaria para toda la población, pero no para la producción industrial masiva de animales o para alimentar automóviles con biocombustible a base de maíz), existen muchas alternativas para aumentar la producción de maíz en México sin uso de transgénicos, aprovechando la enorme diversidad y riqueza histórica de saberes y semillas nativas, en complementación horizontal con la producción de semillas en instituciones públicas y sin patentes. Por ejemplo, las propuestas de Antonio Turrent y José Antonio Serratos, que plantean que México puede duplicar la producción actual de maíz con estrategias multifáceticas y descentralizadas, sin transgénicos ni trasnacionales.

Pero la realización de este tipo de propuestas afirmarían la soberanía alimentaria y la autonomía campesina e indígena, y eso sí, es un problema de fondo para que los señores feudales (nacionales y transnacionales) puedan seguir especulando y lucrando con las semillas que han robado de la creación campesina.

* Investigadora del Grupo ETC

Mientras en México empresas y gobierno intentan imponerlos, crece el rechazo mundial a los transgénicos

Mientras en nuestro país la industria transgénica y los biotecnólogos aprovechan la crisis en el precio de la tortilla para promover las siembras de maíz transgénico, en el mundo aumenta el rechazo de agricultores, campesinos y gobiernos a esta tecnología, dio a conocer Greenpeace

Greenpeace México

Boletín 0703 / 18 de enero de 2007 "En México la industria biotecnológica pretende engañar a la sociedad y convencer a las autoridades para aprobar la siembra de transgénicos en México, prometiendo altos rendimientos y disminución de uso de agrotóxicos, lo que no han comprobado ni siquiera en Estados Unidos, de acuerdo a un reporte de abril del 2006 del propio Departamento de Agricultura (USDA) de ese país (1)", dijo Areli Carreón, de la campaña de transgénicos de Greenpeace México.

"Los transgénicos no son una solución para la producción de maíz en México porque no contamos con las condiciones de producción que requieren para prosperar, esto es, amplias extensiones de monocultivo altamente tecnificado, con riego y con el uso de un paquete tecnológico que los campesinos mexicanos no pueden costear. Para que se cumpliera la promesa de elevar los rendimientos de maíz a los niveles de los Estados Unidos con estas semillas tendríamos que modificar nuestra orografía, nuestra disponibilidad de agua, la tenencia de la tierra y cambiar nuestra cultura, forjada alrededor del maíz. En pocas palabras tendríamos que dejar de ser México".

La verdadera solución para mejorar la producción del maíz requiere de un cambio de fondo en las políticas públicas para el campo y la producción de alimentos, como hemos coincidido ambientalistas, organizaciones campesinas, indígenas, sociales y científicos e investigadores. Antes que permitir la siembra de transgénicos, el gobierno de México debe invertir en proteger y cultivar nuestra biodiversidad de maíz está perfectamente adaptada para resistir a plagas, sequía, inundación, viento, alcalinidad o acidez de los suelos. Esta riqueza genética es un patrimonio exclusivamente mexicano que debemos proteger y aquilatar.

"¿Por qué vamos a apostarle a una tecnología riesgosa para la salud y el medio ambiente, propiedad privada de unas cuantas corporaciones transnacionales que cobran regalías por su uso, que incrementa el uso de agrotóxicos dañinos y que es rechazada por los consumidores de mercados globales tan importantes como Europa, China, Japón y Australia? ¿Debemos permitir la contaminación de nuestra riqueza genética de maíz, sólo porque es un buen negocio para unas cuantas corporaciones transnacionales?", preguntó Carreón.

"Hoy aparece el reporte anual de ISAAA (International Service for the Acquisition of Agri-biotech Applications) dando cifras alegres inverosímiles sobre el supuesto crecimiento del uso de los transgénicos en el mundo. Estos datos se sustentan sólo en información provista por las propias compañías dueñas de esta tecnología, interesadas en impulsar su uso. No son una fuente imparcial y fiable de información. Las promesas falsas, el engaño y la falta de información sobre los transgénicos son las herramientas con las que las corporaciones biotecnológicas pretenden hacer jugosos negocios en México, poniendo en peligro de contaminación irreversible nuestro país, centro de origen y biodiversidad del maíz", dijo Carreón.

Rechazo global a los transgénicos, documenta Greenpeace

El documento Reacción global contra los transgénicos en 2006, publicado hoy por Greenpeace Internacional, provee evidencia sólida del rechazo global de agricultores, consumidores y gobiernos a la siembra de transgénicos. Este documento fue presentado en el contexto del lanzamiento del reporte anual de ISAAA (International Service for the Acquisition of Agri-biotech Applications), organización financiada por la industria agroquímica.

"Hay evidencia irrefutable de que gobiernos, agricultores y consumidores alrededor del mundo reconocen que los transgénicos son impredecibles, inviables o sin duda peligrosos", dijo Jeremy Tager, de Greenpeace International, "La reacción de los mercados globales al reciente escándalo de contaminación del arroz con transgénicos es de grandes proporciones ya que algunos países han decidido prohibir el cultivo de todos los transgénicos en sus territorios. Rumania, por ejemplo, que tenía 85 mil hectáreas sembradas con soya transgénica en el 2005, reducirá esa superficie a cero en este año"

Notas:

1. The First Decade of Genetically Engineered Crops in the United States USDA, abril, 2006, página 9 elaborado por Jorge Fernández-Cornejo y Margriet Caswell.
2. Vea el Reporte Reacción global contra los transgénicos en 2006 aquí.

Para mayor información comunicarse con Cecilia Navarro a los teléfonos 5530-2165 ext. 220 y al 04455-5172-9869 o visitar la página www.greenpeace.org.mx

ISLANDS AT RISK – GENETIC ENGINEERING IN HAWAI'I

New video now available for activists and house parties January 2007

Contact: Brian Smith, 510-550-6714

Honolulu, HI - Earthjustice announces a new video entitled Islands at Risk – Genetic Engineering in Hawai'i. This half-hour program explores a subject that has received little attention in the media but involves a potential public health and safety issue of enormous consequence.

Focusing on local experiments with genetically modified organisms (GMOs), the program features local Hawai'i farmers, teachers, legal and medical experts, and community activists who share their perspective on the genetic engineering of crops and the patenting of life forms.

"Hawai`i has been called the GMO testing capitol of the world because, in the past ten years or so, we have had here more than 2,000 field tests of experimental genetically-engineered crops in more than 6,000 locations around our small state," says Earthjustice attorney Paul Achitoff in the video. "And this is more than any other place in the world."

Earthjustice has won recent lawsuits in federal and state courts challenging the introduction of these experimental crop tests in the islands without first assessing the environmental and human health impacts.

Islands at Risk – Genetic Engineering in Hawai'i looks at some of the possible impacts, including allergic and immune system responses from exposure to biopharmaceutical crops - both in humans and in Hawai'i's endangered species - and contamination of regular food crops such as papaya, taro, coffee and corn with genetically modified versions of those crops.

"Some people say it's a tiny risk," says Kaua'i taro farmer Chris Kobayashi in the video, "but it's a huge risk."

Some of that risk is described by medical doctor, public health officer and World Health Organization consultant Dr. Lorrin Pang of Maui who calls for more oversight of the genetic engineering industry. Regarding the substances introduced into the cells of GMO plants, Pang states, "These things are not benign. These things are quite unknown. The kinds of studies we do for drugs and vaccines are exactly what genetically-engineered food needs."

Aside from health issues, the video focuses on the economics of the current state government policy of subsidizing the biotech industry. Local organic farmers growing coffee, papaya, taro and corn point out that genetically engineered produce does not command the export market prices of conventionally-grown and organic produce. Many countries either refuse to import GE food or require labeling. "We're going in the wrong direction for economic development," says international legal expert Mililani Trask. "We need to re-assess it."

Trask also discusses the practice of patenting Hawaiian life forms, calling it a form of bio-piracy. "We Kanaka Maoli (Native Hawaiians) are claiming our inalienable right to the biodiversity of our lands. This is the heart of what we are in terms of our survival, our ability to maintain our health."

The recent attempt by the University of Hawai'i to patent taro, honored as an ancestor of the Hawaiian people, is recounted in the video by Moloka'i hunter and Hawaiian activist Walter Ritte. His and others' successful efforts to persuade the UH to drop their patents on new hybrid Hawaiian taro varieties was a signal to the whole biotechnology industry, Ritte says in the video, that "you cannot own our ancestors."

The issue of food security and the world's future ability to feed itself is discussed by local farmers Una Greenaway and Nancy Redfeather.

"By choosing the path of genetically-engineered agriculture, we are narrowing significantly the amount of seed varieties that are available to the farmer today," says Redfeather.

The video ends with a vision of Hawai'i as a model for sustainable tropical agriculture. "Hawai'i is a niche specialty market for amazing things: coffee, pineapple, banana, flowers. We can actually support ourselves with this," says mixed organic farmer Melanie Bondera.

The program was produced for Earthjustice by Joan Lander and Puhipau of the documentary production team Na Maka o ka 'Aina. Copies are available at http://www.namaka.com

Watch a clip of the video online here: http://www.youtube.com/watch?v=VVwulgaGDa0

Media seeking review copies please contact Brian Smith bsmith@earthjustice.org

Bioseguridad bilateral

El acoso de la bioseguridad bilateral. Cómo las corporaciones utilizan los canales de comercio bilateral para debilitar las regulaciones sobre biotecnología

GRAIN y African Centre for Biosafety

El sector de los agronegocios ha estado batallando para dar una respuesta a la oposición mundial a los alimentos modificados genéticamente (transgénicos) desde que a mediados de la década de 1990 los agricultores comenzaron a sembrar las semillas manipuladas en los laboratorios. Las empresas transnacionales aspiran a que haya normas internacionales débiles y predecibles que no restrinjan el comercio de sus productos

Pero la resistencia social a los alimentos transgénicos les está complicando de distintas formas. Desde la proliferación de “zonas libres de transgénicos” locales y boicots de los consumidores a los alimentos transgénicos hasta la aprobación de leyes nacionales e incluso locales sobre el etiquetado de trasngénicos, el escenario regulatorio para la biotecnología agrícola está en constante movimiento, lo cual tiene consecuencias directas para las bases de referencia empresariales. La situación es especialmente problemática para el pequeño cartel que controla el comercio mundial de granos. Pero en lugar de abandonar los cultivos transgénicos frente a la referida resistencia, el grupo está saboteando agresivamente todos los procesos por los cuales los gobiernos podrían regular autónomamente el comercio de alimentos transgénicos para humanos o animales. Hacen esto conjuntamente con las compañías de semillas transgénicas y de plaguicidas, poniendo presión toda vez que pueden –en foros multilaterales y, cada vez más, a través de las vías bilaterales.

La utilización creciente de los espacios bilaterales como una forma de ejercer presión política no es exclusiva de la biotecnología agrícola. Ocurre en todos los sectores, especialmente a través del aumento explosivo de los tratados de libre comercio (TLC), que llenan el vacío dejado por la ruptura de las conversaciones comerciales mundiales en la Organización Mundial de Comercio (OMC). A través de los tratados bilaterales y de las estructuras de supervisión que crean las empresas, éstas logran tener acceso directo – por detrás de bambalinas – a los gobiernos, contando con el respaldo del poder político de la bandera de su país de origen. Los acuerdos resultantes sirven inevitablemente a dos necesidades básicas de las empresas: fortalecer la propiedad sobre sus bienes (a través de la propiedad intelectual y los derechos de los inversionistas) y lograr normas regulatorias que se adapten a sus intereses (a través de normas de salud y de seguridad). Este informe analiza cómo y por qué las empresas se apoyan cada vez más en el ámbito del comercio bilateral para dar forma a las políticas regulatorias en todo el mundo sobre la alimentación transgénica para seres humanos y animales.

LEA EL RESTO

Grupo ETC en Nairobi denuncia biología sintética

http://www.ipsnews.net/news.asp?idnews=36239

Group Seeks Ban on "Living Machines"

Stephen Leahy

BROOKLIN, Canada, Jan 20 2007 (IPS) - Anyone with a laptop and a mailbox could create their own bacteria or virus, for good or ill, thanks to a rapidly evolving new technology called synthetic biology, activists warn.

Companies are jumping into synthetic biology and beginning to commercialise and patent bits of constructed DNA and other molecules that can be used to create living machines in the near future, the Canadian-based ETC Group warn in their report "Extreme Genetic Engineering: An Introduction to Synthetic Biology" which will be released at the World Social Forum (WSF) in Nairobi, Kenya Saturday.

"Today, scientists aren't just mapping genomes and manipulating genes, they're building life from scratch," said Pat Mooney, the executive director of ETC Group.

"And they're doing it in the absence of societal debate and regulatory oversight," Mooney said in a statement.

Although related to biotechnology, synthetic biology combines biology and engineering to build entirely new biological entities from the ground up.

In the far future, some proponents of the new technology believe synthetic biologists could construct DNA molecules and other molecular bits to grow an acorn that would become an oak tree that grows into the perfect shape of a dining room table.

More practically, researchers are using the technology to develop cheaper biofuels and drugs, remediate climate change and much more.

"Synthetic biology has the potential to transform society," says Robert Holt, a research scientist at the Genome Sciences Centre of the British Columbia Cancer Research Centre.

However, it is early days and hard to say whether important products of this new technology are years or decades away, Holt told IPS.

There are no completely new synthetic organisms yet. Scientists have recreated a polio virus and a bacteriophage -- the latter took just two weeks in 2004. A bacteriophage is a very simple life form, with just 5,000 base pairs in its genetic map. The human genome has three billion pairs.

Bacteria have around four million base pairs and the world's first de novo bacterium is expected to be announced some time this year.

"This will likely be self-replicating like other bacteria," said Hope Shand of the ETC Group from her office in North Carolina.

Self-replication poses special risks, especially in the environment, and for this reason the ETC Group wants an immediate global ban on the environmental release of these synthetic organisms.

The technology to do synbio is now accessible all around the world, Shand told IPS.

The science has evolved such that using a laptop computer, published gene sequence information and mail-order synthetic DNA, just about anyone has the potential to construct genes or entire genomes from scratch -- including those of lethal pathogens.

Each year students from around the world compete at the Massachusetts Institute of Technology's (MIT) International Genetically Engineered Machine to create new living things. Last year students collected various DNA components from scientists and from MIT's "biobricks" genetic repository, placed them into a string of DNA, and inserted this into bacteria to create a new strain of E. coli that smells of mint and bananas.

Those biobricks, by the way, are also freely available on-line to anyone.

"The pace of development is astonishing. In few years scientists will be able to synthesise new viruses and bacteria," she Shand said.

Bioweapons and bioaccidents are cause for real worry.

This rapid development "increases the incremental risk for biological attack", writes Roger Brent, director and president of the Molecular Sciences Institute in Berkeley, California in an article titled "Power and Responsibility" published late last fall by MIT.

And it is also likely to spawn "DNA hackers" at the high school and undergraduate engineering levels in the future, Brent suggests.

However, Brent would like to see the U.S. government spend 50 million dollars by 2010 on open source standard parts, genes encoding enzymes relevant to carbon fixation, alcohol synthesis, energy storage materials, plant derived materials and functions, and chemical remediation and recycling. But strong technical defences and social norms, including punishment of pathogen-makers, would have to be in place, he writes.

Governments have not even begun to consider how to regulate the new technology, says Shand.

"We need a broad and open discussion between civil society, governments and the scientific community about the benefits and risks," she said.

Patent, intellectual property issues and the privatisation of life forms also need to be discussed, she said, adding that "self-regulation by the scientific community and industry is not good enough."

Last year, 38 civil society organisations released an open letter calling for an international discussion and review of the social, ethical and economic implications of synthetic biology.

"There will be a lot of people in Nairobi (attending the WSF) who will be eager to learn about this new technology," Shand said.

Informe sobre biología sintética

Ingeniería genética extrema: una Introducción a la Biología Sintética,
estará disponible en español en febrero próximo

Boletín de Prensa
Grupo ETC
16 de enero de 2007
www.etcgroup.org

Un nuevo informe del Grupo ETC concluye que los riesgos sociales y ambientales de la biología sintética rebasan con mucho los peligros y abusos de la biotecnolgía. El texto, de 70 páginas, puede descargarse sin costo alguno en el sitio web del Grupo ETC, por ahora en inglés y el próximo mes en español: http://www.etcgroup.org

“La ingeniería genética es cosa del pasado,” afirmó Pat Mooney, Director Ejecutivo del Grupo ETC. “Hoy, los científicos no solo mapean genomas y manipulan genes, sino que están construyendo la vida desde cero, y sin debate social alguno o siguiendo normas de ningún tipo, afirmó Mooney.

La biología sintética —que podríamos decir es ingeniería genética en esteroides— es posible por la convergencia de la biología, la computación y la ingeniería a nivel nanoescalar. Con una computadora portátil, secuencias genéticas públicas y ADN sintético que puede adquirirse mediante el correo, casi cualquiera puede construir genes o genomas enteros (incluso patógenos letales) desde cero. Los científicos predicen que dentro de los próximos dos a cinco años será posible sintetizar cualquier virus. La primera bacteria de novo debutará en 2007; en los próximos cinco a 10 años genomas bacterianos simples podrán sintetizarse cotidianamente y será muy fácil diseñar un genoma, insertarlo en una celda bacteriana vacía y ¡voilà! darle vida a un organismo autorreplicante. Otros esperan reconfigurar las rutinas genéticas de los organismos existentes para que desempeñen nuevas funciones, como fabricar medicamentos o químicos de gran valor.

Un grupo de científicos empresarios, como el extravagante J. Craig Venter, están creando compañías de biología sintética con dinero del gobierno y capital de riesgo. Esperan comercializar nuevas partes biológicas, artefactos y sistemas que no existen en el mundo natural —algunos de los cuales se están diseñando para actuar en el ambiente. Los promotores de la biología sintética insisten que es la clave para biocombustibles baratos, la cura para la malaria y la solución al cambio climático, todas estas ideas muy impactantes para los medios de comunicación, con las cuales esperan suavizar las críticas del público en torno a esta tecnología tan peligrosa y controvertida. A fin de cuentas, la biología sintética abre el acceso a herramientas para construir armas biológicas, patógenos letales y organismos artificiales que amenacen a los pueblos y al planeta. No solo nos amenaza el bio-terror, sino el bio-error, advierte el Grupo ETC.

A pesar de la insistencia en la biología de libre acceso, las corporaciones y los académicos están obteniendo patentes monopólicas exclusivas sobre los productos y procesos de la genómica sintética. Igual que con la biotecnología, el poder para crear vida artificial podría estarse concentrando en la manos de las más grandes empresas multinacionales. A medida que la síntesis genética es más veloz y más barata, será más fácil sintetizar un microbio que encontrarlo en la naturaleza o en un banco de genes. Las muestras biológicas secuenciadas y almacenadas de manera digital se moverán instantáneamente a través del planeta y serán resucitadas en los laboratorios de las corporaciones a miles de millas de distancia, lo cual traerá como consecuencia que ya no se dé importancia a las prácticas de conservación de la riqueza genética y creará nuevas tensiones en las negociaciones internacionales sobre la biodiversidad.

“El año pasado, 38 organizaciones de la sociedad civil rechazaron la propuesta de que la biología sintética debía ‘autorregularse’, hecha por un puñado de biólogos trabajando en ello” informó Kathy Jo Wetter del Grupo ETC. “Debe ponerse en primer plano el debate amplio sobre las implicaciones sociales, económicas y éticas de la biología sintética, debate que no debe restringirse a los temas de la inocuidad o la bioseguridad”.

Las herramientas para sintetizar los genes y genomas son muy accesibles y están sofisticándose rápidamente. El nuevo informe del Grupo ETC concluye que no es suficiente con regular la biología sintética a nivel nacional. Las decisiones en torno a ello deben tomarse en el contexto global, con gran participación de la sociedad civil y los movimientos sociales. En congruencia con el Principio de Precaución, el Grupo ETC insiste en que por lo menos debe prohibirse inmediatamente la liberación en el ambiente de los organismos sintéticos de novo hasta que haya un amplio debate social y un fuerte control por parte de los gobiernos. El texto de ETC Ingeniería genética extrema: Introducción a la biología sintética podrá descargarse sin costo, en español, a partir de febrero en www.etcgroup.org.

Para mayor información sobre el informe de biología sintética, contactar a:

Hope Shand or Kathy Jo Wetter, ETC Group
hope@etcgroup.org +1 919 960-5767
kjo@etcgroup.org +1 919 960-5223

Silvia Ribeiro
silvia@etcgroup.org + 52 5555 6326 64

The truth about the ISAAA report

GLOBAL GM CROP REPORT A BEAT UP

GENE ETHICS: NEWS MEDIA RELEASE - JANUARY 20 2007

Industry's annual review of genetically manipulated (GM) crops shows they stalled a long time ago. An International Service for Acquisition of Agro-biotechnology Applications report was published today. (www.isaaa.org/Resources/Publications/briefs/default.html) "ISAAA makes unsupported claims, inflates its figures and ignores the negative impacts of GM crops," says Gene Ethics Director, Bob Phelps.

"For instance, Iran is again wrongly listed as growing 50,000 hectares of commercial GM rice, which is not approved and is not being grown," he says.

"Romania is also listed as growing 100,000 hectares of GM soybean but this crop is now banned and the country is being decontaminated to return it to GM-free," he says.

"ISAAA claims commercial GM crops are a global industry but their own figures show 99% grew in just eight countries last year - USA 53.5%; Argentina 17.6%; Brazil 11.3%; Canada 6%; India 3.7%; China 3.4%; Paraguay 2%; and South Africa 1.4%," he says.

"The range of GM crops also stalled in 1996 when four broad-acre commercial crops - soy, corn, cotton and canola - were first grown. Not one has been added since," he says.

"And these crops still have just two commercial GM traits - tolerance to being over-sprayed with weed killer and making their own insect toxins. Both add more chemicals to our environment and foods," Mr Phelps says.

"Australian governments would be foolish to allow commercial GM canola into Australia because, even in this weak field, GM canola runs a distant last since 1999," he says.

"The report emphasizes that 10.3 million farmers grew GM crops in 2006, but this is just 0.7% of farmers world-wide. And just 600,000 farmers grew 85% of all GM crops on industrial farms in North and South America. Small third world farmers are misused as fodder in the ISAAA's PR war," he says.

"GM technology has been overtaken by smarter, more precise and successful genetic science - genomics and proteomics - in tandem with traditional breeding,' he says.

"The ISAAA is flogging a dead horse," he says.

"Shoppers and farmers will ensure that genetically manipulated seeds, crops and foods are rejected around the world," Mr Phelps concludes.

More comment: Bob Phelps 03 9347 4500 (O) 03 9889 1717 (H) 0408 195 099 (Mob)

Diez años

The Global Status of Genetically Engineered (GE) Crops: 10 years of continuing rejection

GREENPEACE INTERNATIONAL PRESS RELEASE

Amsterdam, 18 January 2007: A summary of global reaction against genetic engineering in 2006, released by Greenpeace today, provides solid evidence that resistance to genetically engineered (GE) crops continues to grow among farmers, consumers and governments.

The Greenpeace summary was released hours before the expected release of an annual report by the International Service for the Acquisition of Agri-biotech Applications (ISAAA), a think-tank supported largely by the agrochemical industry.

"There is irrefutable evidence (1) that governments, farmers and consumers throughout the world recognise that genetic engineering is unreliable, unviable or downright dangerous," said Jeremy Tager, campaigner for Greenpeace International, "Market reaction to the recent rice contamination scandal was of near epidemic proportions; some countries are banning GE altogether. Romania, for instance, which had 85,000 hectares planted with GE soy in 2005, will drop to zero this year, in keeping with a new government policy banning the cultivation of GE soy."

The most significant demonstration of GE rejection occurred in the aftermath of Bayer's LLRICE601 contamination scandal. In August 2006, the US government announced that significant amounts of US long grain rice had been found to be contaminated with an unapproved genetically engineered variety, LLRICE601; the news elicited strong reactions from rice farmers and processors, as well as governments worldwide:

The Rice Producers of California and a major rice mill in the state, Sunwest Foods, have called for a ban on any cultivation of GE rice (including field trials) in California.

Large sectors of the rice industry, including Ebro Puleva, the world's largest rice processor, committed to being GE-free.

Rice traders of two of the largest rice exporting countries, Thailand and Vietnam, have signed an agreement that commits them to being GE-free, capitalizing on new market opportunities that have opened up as a result of the contamination of US rice supplies with Bayer's GE rice.

The Chinese Biosafety Committee once again requested further data and assessment on the safety of GE rice, thereby again delaying a decision about commercial approval, even though the varieties have been under active consideration by the committee for over two years.

The All India Rice Exporters' Association formally requested that the Indian government prohibit field trials of GE rice in basmati rice-growing states. Rice farmers in India burnt down GE-rice test plots that could potentially contaminate their own fields.

Rakesh Tikait, national spokesperson for the Bharathiya Kisan Union, (BKU) one of the largest farmers' groups in India, was straightforward in his condemnation of GE, saying, "The threat to farmers' livelihoods in India is clear. Examples from across the country of Bt cotton failures show that this technology is unsafe for humans and the environment, and that it can neither be controlled nor regulated. We consider the threat serious enough to warrant the destruction of test fields of GE rice to stop its introduction and protect ourselves."

Chip Struckmeyer, a rice farmer from California, agreed, "US rice producers took a big hit financially when rice was found to be contaminated with unapproved varieties. It's clear our customers don't want genetically engineered rice. Why on earth would we plant it?"

"ISAAA might claim that genetic engineering has been a success, with consistent increases in global acreage. But the global reaction to the Bayer rice contamination scandal of 2006 provides a sharp contrast to the rosy picture they're painting. It is overwhelmingly evident that the GE industry will not be able to convince consumers to eat GE rice, wheat, aubergine, or anything else. With governments unwilling to allow it, farmers unwilling to grow it and consumers unwilling to buy it, it is clear that genetic engineering has no place in our future," concluded Tager.

Notes to Editor:

1. See 'Global reaction against Genetic Engineering in 2006', http://www.greenpeace.eu/downloads/gmo/
GlobalStatusGECrops2006.pdf

For further information please contact:

Namrata Chowdhary, Greenpeace International Communications: +31 646 1973 27 namrata.chowdhary@int.greenpeace.org

Jeremy Tager, GE Campaigner Greenpeace International: + 31 646 2211 85 Jeremy.tager@int.greenpeace.org

El lado oscuro de la medicina nanotecnológica

La Jornada, México, 23/12/2006

El lado oscuro de la medicina nanotecnológica

Silvia Ribeiro*

La convergencia de nuevas tecnologías como la genómica y la nanotecnología promete avances que revolucionarían el sistema de diagnóstico y tratamiento de muchas enfermedades que hoy son difíciles o imposibles de curar para la medicina convencional. Pero más allá de avances puntuales para quienes los pueden pagar lo que está fuera de dudas es que estos enfoques cada vez más sofisticados y fragmentarios están revolucionando la forma de hacer ganancias en el sector farmacéutico. Por ejemplo, como herramientas para prolongar la patente de medicamentos y por tanto su monopolio por parte de las empresas. Por otra parte, la nanotecnología parece estar creando nuevos problemas de salud, y paradójicamente, desvía fondos que deberían dedicarse a problemas básicos de salubridad, prevención y atención primaria de la salud, aspectos sobre los cuales se sabe con certeza que tienen un impacto positivo amplio en la salud de la mayoría de las poblaciones.
Según documenta el reciente informe del Grupo ETC "Medicina nanológica: aplicaciones médicas de la nanotecnología" (www.etcgroup.org), a mediados de 2006, estaban en etapa de pruebas clínicas o en distribución comercial más de 130 fármacos y sistemas de administración de medicamentos con base nanotecnológica, además de 125 dispositivos y reactivos de diagnóstico. Mientras que en 2005, el mercado de la medicina habilitada nanotecnológicamente (incluyendo fármacos, terapias y diagnósticos) fue de mil millones de dólares estadunidenses, para 2010 alcanzaría 10 mil millones. La Fundación Nacional de la Ciencia de Estados Unidos predice que la mitad del mercado de productos farmacéuticos usará nanotecnología en el 2015.

Veamos un ejemplo: en enero de 2005, la Administración de Fármacos y Alimentos de Estados Unidos (FDA) aprobó el uso del medicamento Abraxene, formulado nanotecnológicamente para el tratamiento de cáncer. Medios especializados lo llamaron "un salto gigantesco para la nanotecnología". Al día siguiente, las acciones de la compañía que lo desarrolló, American Pharmaceutical Partners (ahora llamada Abraxis Bio Science) subieron más de 50 por ciento y su presidente se convirtió ese año en multimillonario.

El primero de octubre de 2006, Alex Berenson dio a conocer en el New York Times otros aspectos de esta historia. Abraxene es una formulación nanotecnológica del taxol (una sustancia activa del árbol del tejo, y por cierto un caso de biopiratería), que ya se usaba contra el cáncer de mama, bajo patente monopólica de Bristol-Myers Squibb. La patente expiró en 2000 y se comenzó a comercializar la versión genérica del taxol, llamada Paclitaxel, a 150 dólares por dosis. El Abraxene es exactamente la misma sustancia, pero al administrarse en nanopartículas cubiertas de albúmina, provoca mucho menos reacciones alérgicas en los pacientes, lo que sin duda es deseable. Sin embargo, no tiene ningún efecto en alargar la vida del paciente ni otras ventajas terapéuticas. Quién realmente saca el mayor beneficio es la empresa, que cobra 4 mil 200 dólares por cada dosis de Abraxene (28 veces más que el genérico) y logró además establecer un nuevo monopolio de patente. Si este es el caso emblemático de la medicina nanotecnológica, queda claro adónde se dirige.

Otras aplicaciones que están en comercialización o en desarrollo son, por ejemplo, nano-sensores que circulan en el cuerpo para detectar niveles de glucosa, colesterol u hormonas, nano-proyectiles que hacen blanco en células cancerosas, nanopartículas que van a un sitio específico del organismo para administrar con precisión un medicamento, nano partículas de plata con alto poder microbicida, armazones nanométricos donde se estimula el crecimiento de tejido óseo y órganos humanos.

Pese a que estas aplicaciones podrían ser útiles, todas ellas van acompañadas, no sólo de la lucha por el monopolio y el afán de lucro de quienes las ponen el mercado, sino también de las incertidumbres que presenta la introducción de nanopartículas en el organismo.¿Dónde van las nanopartículas luego de cumplir su función? La misma causa por la que son útiles no son rechazadas porque el sistema inmunológico no los detecta , es un problema en sí mismo, ya que no está claro lo que sucede finalmente con estas pequeñísimas partículas en los organismos vivos y hay cada vez más evidencias de toxicidad.

Un dato significativo, es el anuncio de la Agencia de Protección Ambiental de Estados Unidos (EPA) en noviembre 2006, de que el uso de nanopartículas de plata debe ser regulado, porque pueden conllevar a daños ambientales. Actualmente, éstas se comercializan como desinfectantes anti-bacteriales, en lavarropas, equipos de aire acondicionado, purificadores de aire, refrigeradores, contenedores de alimentos, eliminación de olor en calzado, entre otros. La EPA considera que durante la producción, uso y/o disposición, las nanopartículas llegan al ambiente, cursos de agua, etcétera y pueden matar organismos benéficos, así como entrar en las cadenas alimentarias, con efectos impredecibles. Esto afecta también a los que plantean este tipo de soluciones para purificación de agua, y por supuesto en el campo médico.

Sin duda, el mayor problema sanitario que padecemos es el capitalismo y el afán de lucro que conlleva, con su extendido síndrome de pobreza e injusticia, que condena a cualquier nueva tecnología a ser una medicina elitista de quienes puedan pagarla. Ninguna nueva tecnología podrá solucionar esta enfermedad social, pero tampoco significa que por sí misma esté libre de problemas. Lo que garantiza el capitalismo es que entren al mercado sin discusión social y como si fueran éxitos, aunque incluso creen nuevos problemas.

* Investigadora del Grupo ETC
www.etcgroup.org

Palabras de Wolbring

Science and technology applications are not value neutral. The intentions, purposes, and actions that shape the direction, advances, and policies for science and technology use, research, and development embody the perspectives; purposes; prejudices; particular objectives; and cultural, economical, ethical, moral, spiritual, and political frameworks of different social groups and society at large.

This is true for any given society in which these human activities take place. Until now inventions have been slow enough to allow society to integrate new science and technology realities into their social fabric and social contract. The speed of these cycles has been steadily increasing, however, allowing less time to evaluate how new science and technology products affect social cohesion and the social contract, and how negative impacts can be mitigated and positive impacts enhanced.

- Gregor Wolbring

Clone Burgers- Minneapolis Star Tribune article

Editorial: Why 'cloneburgers' are a bad way to go
The danger isn't about food safety; it's about food security.

Published: January 16, 2007

If beef is what's for dinner at your house, you undoubtedly know the U.S. Food and Drug Administration is preparing to approve the sale of cloned meat and milk to U.S. consumers.

But a related and potentially more significant announcement probably escaped your notice: Researchers for a United Nations agency reported last month that livestock breeds around the world are disappearing at alarming rates, with as many as one-fifth of cattle, hog, goat, horse and poultry varieties facing extinction. Some 190 breeds have vanished in the last 15 years, and perhaps another 1,500 are already thought to be at risk.

These extinctions are driven by agricultural practices that perpetuate the most profitable breeds and neglect the rest. The results are a shrinking gene pool and, potentially, threats to global food security. The connection to cloning is that this high-tech practice is likely to make matters worse, not better.

Those issues don't really concern the FDA, whose OK for cloned animal products will be based on their safety for human health, a conclusion based in turn on tests showing that meat and milk from clones are identical to those from animals born naturally. But they ought to concern Congress -- and they ought to prompt consumers to think more broadly about how their food is produced.

For American consumers, at least, the advancing globalization and industrialization of agriculture have made many foods plentiful, cheap and available in every season. But there have been tradeoffs, too, perhaps the most noticeable being the increasing flavorlessness of mass-produced chicken, beef, pork and salmon.

Among some shoppers there is growing awareness that factory-like livestock operations produce animals in conditions ranging from misery to torture, while promoting the extinction of small-scale farming and farm-dependent rural communities. But most find it easy to look the other way.

When biotech food issues occasionally make the headlines, it is nearly always for a wrong reason. The big risk posed by genetically engineered crops isn't that they'll poison people, it's that they may transfer their new traits to other plants, with catastrophic consequences. The problem with irradiation isn't that consumers will get radiation poisoning, it's that signs of declining freshness are masked.

And the big problem with the coming use of cloned livestock on production scales is not that "cloneburgers" will be dangerous to human health, nor even the uncomfortable reality that animals produced this way are much likelier to be defective at birth.

It's that this way of engineering foods, like so many previous production-oriented manipulations, will continue to narrow the diversity of food sources and thereby enlarge their vulnerability to disease, pests or other causes of collapse. Such is the unavoidable high price of cheap food.

News Release
ETC Group
January 16, 2007
www.etcgroup.org

Extreme Genetic Engineering: ETC Group Releases Report on Synthetic Biology

Findings to be presented at World Social Forum in Nairobi - 20-25 January

A new report by the ETC Group concludes that the social, environmental and bio-weapons threats of synthetic biology surpass the possible dangers and abuses of biotech. The full text of the 70-page report, Extreme Genetic Engineering: An Introduction to Synthetic Biology, is available for downloading free-of-charge on the ETC Group website: www.etcgroup.org

"Genetic engineering is passe," said Pat Mooney, Executive Director of ETC Group. "Today, scientists aren't just mapping genomes and manipulating genes, they're building life from scratch - and they're doing it in the absence of societal debate and regulatory oversight," said Mooney.

Synbio - dubbed "genetic engineering on steroids" - is inspired by the convergence of nano-scale biology, computing and engineering. Using a laptop computer, published gene sequence information and mail-order synthetic DNA, just about anyone has the potential to construct genes or entire genomes from scratch (including those of lethal pathogens). Scientists predict that within 2-5 years it will be possible to synthesise any virus; the first de novo bacterium will likely make its debut in 2007; in 5-10 years simple bacterial genomes will be synthesised routinely and it will become no big deal to cobble together a designer genome, insert it into an empty bacterial cell and - voila - give birth to a living, self-replicating organism. Other synthetic biologists hope to reconfigure the genetic pathways of existing organisms to perform new functions - such as manufacturing high-value drugs or chemicals.

A clutch of entrepreneurial scientists, including the gene maverick J. Craig Venter, is setting up synthetic biology companies backed by government funding and venture capital. They aim to commercialise new biological parts, devices and systems that don't exist in the natural world - some of which are designed for environmental release. Advocates insist that synthetic biology is the key to cheap biofuels, a cure for malaria, and climate change remediation - media-friendly goals that aim to mollify public concerns about a dangerous and controversial technology. Ultimately synthetic biology means cheaper and widely accessible tools to build bioweapons, virulent pathogens and artificial organisms that could pose grave threats to people and the planet. The danger is not just bio-terror, but "bio-error," warns ETC Group.

Despite calls for open source biology, corporate and academic scientists are winning exclusive monopoly patents on the products and processes of synthetic genetics. Like biotech, the power to make synthetic life could be concentrated in the hands of major multinational firms. As gene synthesis becomes cheaper and faster, it will become easier to synthesise a microbe than to find it in nature or retrieve it from a gene bank. Biological samples, sequenced and stored in digital form, will move instantaneously across the globe and be resurrected in corporate labs thousands of miles away - a practice that could erode future support for genetic conservation and create new challenges for international negotiations on biodiversity.

"Last year, 38 civil society organizations rejected proposals for self-regulation of synthetic biology put forth by a small group of synthetic biologists," said Kathy Jo Wetter of ETC Group. "Widespread debate on the social, economic and ethical implications of synbio must come first - and it must not be limited to biosecurity and biosafety issues," said Wetter.

The tools for synthesising genes and genomes are widely accessible and advancing at break-neck pace. ETC Group's new report concludes that it is not enough to regulate synthetic biology on the national level. Decisions must be considered in a global context, with broad participation from civil society and social movements. In keeping with the Precautionary Principle, ETC Group asserts that - at a minimum - there must be an immediate ban on environmental release of de novo synthetic organisms until wide societal debate and strong governance are in place.

* * * * * * * * *

Synthetic Biology Report Goes to World Social Forum

ETC Group will host three workshops and participate in several other events at the upcoming World Social Forum in Nairobi, 20-25 January. All events will take place at the Moi International Sports Center (Kasarani suburb). ETC Group's workshops and other events in which we'll participate appear below. Watch our web site for updates: http://www.etcgroup.org

January 21:
"What Next?" Hosted by the Dag Hammarskjold Foundation

January 22:
"Ban Terminator! The Global Campaign to Ban Terminator: from Brazil (2006) to Bonn (2008)" ETC Group workshop

"Regaining control of our natural resources" Hosted by Friends of the Earth International

"New technologies - implications for health, environment & democracy"
Hosted by the Dag Hammarskjold Foundation

January 23:
"From Biotech to Nanotech and back again - Synthetic Biology and Nano Foods: New technologies that will challenge human society and Food Sovereignty" ETC Group workshop

"The New Politics of Food in Africa: Gates Foundation, the Second Green Revolution and the role of international institutions" ETC Group workshop

ETC contact information:

Pat Mooney and Kathy Jo Wetter of ETC Group are attending the World Social Forum. We have a booth at the WSF venue and / or can be reached by email and the following mobile phone number:

Pat Mooney: etc@etcgroup.org Mobile: +1 613 261 0688
Kathy Jo Wetter: kjo@etcgroup.org

For further information about the report on Synthetic Biology, please contact:

Hope Shand or Kathy Jo Wetter, ETC Group
hope@etcgroup.org +1 919 960-5767
kjo@etcgroup.org +1 919 960-5223

Silvia Ribeiro
silvia@etcgroup.org + 52 5555 6326 64

GM Grapevines & Toxic Wines

Prof. Joe Cummins and Dr. Mae-Wan Ho

Synthetic genes, toxins and cyanide gas are some of what to expect from wines on your dinner table.

The modification of grapevines has gone beyond the humdrum of Bt and herbicide tolerance of most GM food crops. The new emphasis is on synthetic genes and proteins, and virus resistance using coat protein gene modifications. The introduction of a cyanogenic toxin into grapevine may be a sign that genetic engineers are growing ever more daring in the recognition that regulators are standing with them against the public. Clearly these new developments are crying out for GM labelling at the very least, and a clean sweep of the regulatory regimes would not come amiss.

"Nada" han hecho contra el hambre los transgénicos

Angélica Enciso

Los cultivos transgénicos no han resuelto los principales problemas a que se enfrentan los agricultores ni se han extendido a todo el mundo, ya que 70 por ciento de estas plantaciones se concentran en sólo dos países: Estados Unidos y Argentina

En un análisis de 1996-2006 denominado ¿Quién se beneficia con los cultivos transgénicos?, la organización Amigos de la Tierra indica que ninguno de los productos genéticamente modificados que están a la venta ofrece ventajas al consumidor en lo referente a precio o calidad y, hasta ahora, "no han hecho nada para aliviar el hambre o la pobreza".

Refiere que la experiencia de más de una década de siembra comercial de estos productos deja como saldo que no han dado respuesta a los principales problemas y desafíos que enfrentan los agricultores en la mayoría de los países, "no han probado ser superiores a los cultivos convencionales".

Agrega que a pesar de la adopción masiva de la soya transgénica en Paraguay y Brasil, los agricultores de estas naciones "continúan en una profunda crisis, y la producción ha caído en los últimos dos años a causa de los precios bajos y el incremento del costo de los insumos, como las semillas modificadas genéticamente".

Indica que los productores de algodón transgénico de Sudáfrica, Colombia, Argentina, Australia y México se han visto seriamente afectados por los bajos precios y las condiciones adversas del tiempo, como la sequía; ese producto "no ha contribuido a mejorar las condiciones de vida, y la crisis del sector algodonero en esos países ha continuado a pesar de la introducción de algodón BT".

Este producto no da respuesta a los principales problemas que enfrentan los agricultores, por lo que un importante número de pequeños productores nacionales están atrapados entre la pobreza y el endeudamiento. "Los cultivos transgénicos han contribuido muy poco o nada a dar respuesta a los grandes problemas que enfrentan los campesinos de la mayoría de las naciones", agrega.

Además ­señala­, los cultivos transgénicos han sido liberados acelerada y ampliamente, sin una adecuada evaluación de su desempeño ni de sus impactos para la salud y el medio ambiente. Sólo el descubrimiento de arroz genéticamente modificado en la cadena alimentaria de Estados Unidos, Europa, Africa y Asia, proveniente de ensayos experimentales, "demuestra la incapacidad o falta de voluntad de la industria en controlar sus productos".

Advierte que la creciente susceptibilidad de la soya transgénica a la sequía pasó inadvertida en Brasil y Paraguay, donde los agricultores sufrieron mucho por las enormes pérdidas de sus cosechas a causa de ese fenómeno climático.

De acuerdo con el informe, los productos transgénicos que se comercializan no han hecho disminuir, sino aumentar el uso de plaguicidas, y su productividad no es mayor que la de las variedades convencionales. "El medio ambiente no ha ganado nada con los transgénicos, que se volverán cada vez más insustentables a mediano y largo plazos", advierte.


La Jornada, México, 10-1-07

Editorial sobre clonación

Food from cloned animals
These products should remain in the lab

By David Schubert
January 3, 2007

It is curious that the U.S. population seems willing to act as guinea pigs solely for the financial benefit of a few companies. This is most recently exemplified by the lack of outcry over the U.S. Food and Drug Administration's move toward allowing the sale of milk and meat from cloned animals without any required labeling. The FDA decision is another example of the continuing sway that the U.S. agricultural biotechnology and chemical companies have over federal agencies.

The conclusion that cloned animal products are safe to eat is based almost completely on data and arguments provided by the companies that will profit from their sale. Similar scenarios allowed the introduction of genetically modified, or GM, foods 10 years ago, and the massive and largely unregulated introduction of pesticides after World War II.

The development of an agricultural system based on chemical pesticides, fertilizers and herbicides led to an increase in farm productivity and cheaper food. But it also blanketed our planet with chemicals now known to cause cancer, birth defects and huge environmental problems as well as bringing about economic disparities between populations who do and do not have the technology. More important, however, is the realization that had we given a little more thought and study to agricultural methods at the time, we would have come up with the more sustainable farming methods that are now being widely adapted.

Innovation and technological advancement are major driving forces for modern society, but they must be done in the context of both need and potential risk. Many European countries have outlawed toxic agricultural chemicals that are still widely used in the United States, and require much more stringent testing for adverse health and environmental effects before the introduction of new ones.

As with cloned farm animals, the introduction of GM food crops into our food supply was allowed by the FDA with essentially no regulatory oversight because it was claimed they were just like normal plants. GM crops were promoted as a way make food cheaper, reduce the need for agrochemicals and eliminate world hunger. Ten years after their introduction, there is no reduction in food cost, the worldwide use of chemicals on the farm has increased greatly, and world hunger is worse than ever. In addition, farmers have lost millions of dollars due to GM crop failures and closed export markets resulting from GM contamination because many countries do not allow GM foods.

The only benefactors of the GM technology have been the small group of companies that control over half of the world's seed supply and make 90 percent of the chemicals used in agriculture. Monsanto is the biggest player, controlling 41 percent of the global seed market for corn and 25 percent for soybeans. Its dominance was achieved through huge contributions to politicians, the intimidation of farmers, bribery and the perpetual harassment of individuals who oppose their views. If absolute control of our food supply is the goal, then the next step for agricultural biotechnology is to dominate the milk and meat markets through animal cloning.

As with the introduction of chemical agriculture and GM plants, animal cloning is a new and untested technology. Its famous first was Dolly the sheep. Cloning involves removing the genetic material from an egg, replacing it with that of the animal to be cloned, and then implanting the egg in the surrogate mother to which the clone is born. The advantage of animal cloning over breeding is that it eliminates the innate randomness of normal breeding and therefore is thought to assure that the desired characteristics are present in each clone. The trade-off, as with GM crops and pesticides, it that the health hazards to the consumer could be significant.

For example, to trick the surrogate mother into thinking that she is pregnant, she must be treated with high levels of hormones that will certainly enter our food supply along with her body parts. In addition, many clones are born with severely compromised immune systems. A good example is Dolly, which led a short, albeit glamorous, life due to multiple medical problems. It will therefore be necessary to treat cloned animals with antibiotics, which will further drive the selection for antibiotic resistant pathogens, already a major medical problem. Indeed, the National Academy of Sciences warned that cloned farm animals would likely increase the incidence of food-borne infections.

A logical extension of cloning is to make transgenic animals that contain genes from plants or other animals. This has in fact been done to solve a problem presented by the use of synthetic growth hormone to force cows to produce more milk. Since the super milk producer gets infections of her udder, the high-tech solution was to make a transgenic cow that produces its own antibiotics. Next up, cattle that make their own barbecue sauce.

Why is there such a drive to produce the type of laboratory-derived food represented by GM crops and cloned animals? Since the major, if not the only, benefactors of GM crop and animal cloning technologies are the companies that own them, it is clear the drive for their introduction is corporate profit. It is always assumed that the market drives the technology, but in the case of agricultural technology, supported by an enormous amount of money and political capital and the fact that the consumers do not seem to care, the reverse is clearly true.

And why are these products readily accepted in a country that has an overabundance of cheap food, while most of the world rejects this approach? The reason the U.S. population does not spend much time thinking about the origin of its food is because it believes the FDA is doing the necessary safety testing. In fact, there is no required safety testing for GM crops; there will be none for cloned animals.

The Europeans do not harbor this assumption because they have experienced dramatic failures of their regulatory agencies in the form of mad cow disease and HIV-infected blood supplies. An additional problem is that in the laboratory we only use guinea pigs in experiments where we can detect the outcome, while any adverse effects of biotech food on human health will be undetectable against the background of current medical problems. Therefore the claim that these foods are safe because there is no evidence of harm is invalid. It would seem to me that the toxic consequences of chemical farming and the failure of GM crop technology to produce any human benefit should force us to question the blind acceptance of yet another untested and unregulated agricultural practice.

Schubert is a professor at the Salk Institute for Biological Studies.

http://www.signonsandiego.com/uniontrib/20070103/news_lz1e3schubert.html

¿Vino transgénico?

GM Wine Sold Unlabelled in the United States

Prof. Joe Cummins exposes the potential hazards of the GM wine yeast that has been approved as safe by the US Food and Drug Administration and advises against drinking US wines

Entrevista a Caruso

Pig Hearts for Humans: What the Public Needs to Know About Biotech Risks

By Heather Gehlert, AlterNet. Posted January 3, 2007.

In her new book, Intervention, former NY Times technology columnist Denise Caruso talks about the risks of life on a genetically engineered planet.

Turn on the TV, open your Internet browser, or click on your inbox and chances are you’ll find an alarming story alerting you to the possibility some new hazard: cancer-causing toxins in your deodorant, mold spores in your kitchen sponge, radiation from your cell phone -- the list goes on.

In an age of information overload, it’s tempting to tune risks out entirely, especially when even the scientific community can’t seem to come to a consensus on some things: One day eggs are good; the next, they’re bad. One day hormone replacement therapy is healthy; the next, it causes cancer.

But, what if you knew that, instead of one product putting you at risk, an entire field of technology was? That’s what former NY Times technology columnist Denise Caruso tackles in her new book, Intervention: Confronting the Real Risks of Genetic Engineering and Life on a Biotech Planet.

Caruso doesn’t use scare tactics -- she doesn’t need to. Instead, she merely points out the risks of living in an age when scientists are recombining DNA from multiple species, experimenting with tissue regeneration by growing human ears on the backs of mice, and looking seriously at pigs for human heart transplants. Even more eye-opening, these innovations are occurring in the near-absence of oversight and with little attempt from government regulators or scientists to educate the public.

So what is life like on a biotech planet? AlterNet interviewed Caruso to find out.

READ ON

BALADA TRANSGENICA

BALADA TRANSGENICA: Biotecnología, Globalización y el Choque de Paradigmas

A LA VENTA EN:

LIBRERIA MAGICA Y LIBRERIA NORBERTO GONZALEZ. Ambas en la avenida Ponce de León en Santa Rita, cerca de la UPR.
LIBRERIA PALIQUES. Centro del Sur Mall en Ponce.
ASI QUE SI. Calle Máximo Gómez en el pueblo de Cabo Rojo. Tel. 538-5162. Internet: www.asiquesi.com.
CASA PUEBLO. Calle Rodulfo González en el pueblo de Adjuntas. Tel. 829-4842.
NATUCENTRO. Mayagüez.

Organica 3. En la parada 18 en Santurce, entre la Baldorioty y la Ponce de León. Tel. 453-2515. email. organica3@earthlink.net. Internet: www.organica3.com.

LIBRERIA EL QUIJOTE. 63 Calle Post Norte, Mayagüez, cerca del RUM.

ALL NATURAL. Calle Verdún #35, Urb. Alamain, Río Piedras. Cerca del cruce de la 65 de Infantería con la carretera a Trujllio Alto. Tel. 754-1499.


SOBRE EL LIBRO:

Desde hace varios años estamos consumiendo alimentos genéticamente alterados, también llamados transgénicos. ¿Qué efectos pueden tener sobre la salud humana y el medio ambiente? ¿Qué interrogantes éticas nos presentan? ¿Qué impactos económicos tienen, especialmente sobre el pequeño y mediano agricultor? ¿Es cierto que estos novedosos productos agrícolas pondrán fin al hambre, como alegan sus proponentes?

Carmelo Ruiz Marrero aborda estas interrogantes en "Balada Transgénica". El autor analiza críticamente las premisas científicas y sociales de la tecnología de la manipulación genética y argumenta que ella está inseparablemente ligada al llamado proceso de globalización económica e implica la integración forzosa de agricultores y consumidores a un orden mundial gobernado por corporaciones transnacionales que conforman un complejo biológico industrial.

Lejos de ser un relato fatalista y lapidario, este libro muestra, a través de las luchas de movimientos sociales alternativos alrededor del mundo, ventanas de lucha y triunfo que muestran el camino hacia una sociedad ecológica y socialmente justa.


Indice:

PROLOGO: De Orocovis a Point Reyes

INTRODUCCION: La batalla campal del siglo XXI

1- EL FUTURO YA NO ES LO QUE ERA ANTES

2- DE LA CONQUISTA COLONIAL AL COMPLEJO BIOLOGICO INDUSTRIAL

3- ¿QUE DICEN LOS CIENTIFICOS?

4- DE LA REVOLUCION VERDE A LA REVOLUCION GENéTICA

5- MARIPOSAS MONARCAS Y VACAS AFLIGIDAS

6- CONTAMINACION GENETICA: UN EXXON-VALDEZ BIOLOGICO

7- BIOPIRATERIA Y BIOCOLONIAJE

8- SEMILLAS SUICIDAS Y GUERRAS BIOLOGICAS

9- LA COSECHA BIOFARMACEUTICA

10- MAS ALLA DE LA BIOTECNOLOGIA: LA INVASION DE LOS NANOBOTS

11- LOS RIESGOS TECNOLOGICOS Y LA “OBJETIVIDAD” DE LA CIENCIA

12- ARROCES DORADOS Y CABALLOS DE TROYA

13- SATYAGRAJA CONTRA LOS TRANSGENICOS

14- EL ESPIRITU DE PORTO ALEGRE

15- AGRICULTURA ECOLOGICA: MáS ALLá DEL PARADIGMA CARTESIANO

16- OTRO FUTURO ES POSIBLE

SOBRE EL AUTOR.

Carmelo Ruiz Marrero, nacido en Santurce en 1967, es un periodista y educador dedicado a esclarecer la problemática ambiental en Puerto Rico y a nivel internacional. Posee un bachillerato en humanidades de la Universidad de Puerto Rico (1991) y una maestría en ecología social de Goddard College en Vermont, EEUU (1995). En 1992 comenzó a publicar escritos en el periódico Claridad, en cuya redacción trabajó de 1997 a 2004. Es además catedrático del Instituto de Ecología Social y becado (Senior Fellow) del Programa de Liderazgo Ambiental. De 2002 a 2004 fue becado también de la Asociación de Periodistas Ambientales.

Con gran frecuencia ofrece charlas y talleres sobre temas como el periodismo ambiental y los impactos de la ingeniería genética a variadas instituciones, incluyendo universidades, escuelas secundarias, grupos comunitarios, ambientalistas, religiosos y de agricultores, el Servicio de Extensión Agrícola y la Junta de Calidad Ambiental.

En 2004 fundó el Proyecto de Bioseguridad de Puerto Rico (http://www.bioseguridad.blogspot.com/) entidad sin fines de lucro que busca educar a la ciudadanía sobre las implicaciones éticas, ecológicas, políticas, económicas y de salud pública de los cultivos y productos genéticamente alterados. También opera la página de internet Haciendo Punto en otro Blog (http://carmeloruiz.blogspot.com/).

Ruiz Marrero es también jefe de redacción del periódico Agrocooperando.

Tough luck, Syngenta

The Struggle for the Expropriation of Syngenta: Showdown Between the Social Movements and Agribusiness in Brazil

by Isabella Kenfield

January 07, 2007

Curitiba, Brazil - The recent decree by Roberto Requião, Governor of the state of Paraná, to expropriate the Syngenta corporation's experimental site in Santa Tereza do Oeste has become a powerful symbol for all interests in the struggle over the future of Brazilian agriculture. The magnitude of Requião's decision was highlighted on November 30th when members of the rural social movements the Via Campesina and the Movement of the Landless Rural Workers (MST) closed the first Meeting of Education in Agrarian Reform, in Cascavel, with a march to the Syngenta site. En route to the march, the movements' busses were halted by a blockade of tractors formed by about 100 members of the Rural Society of the West (SRO), an elite group representing the interests of large landowners and commercial agricultural producers in western Paraná. Some SRO members were on horseback and armed with guns. As the marchers began to cross the barricade on foot, a violent conflict began. Shots were fired into the air, and pieces of wood were used to beat the marchers. While no one was hospitalized, the confrontation resulted in the injury of nine people. According to Alessandro Meneghel, President of the SRO, the blockade was created "to show that the rural producers will no longer peacefully accept land invasions and political provocations."

The conflict over Syngenta began on March 14th when about six hundred members of the Via Campesina and the MST occupied the 127-hectare locale after the Brazilian Institute for the Environment and Natural Resources (IBAMA), the federal environmental agency, confirmed that Syngenta had illegally planted twelve hectares of genetically-modified (GM) soybeans there. The planting was illegal because the site is located within the protective boundary zone of the Iguaçu National Park, and under Brazilian federal law it is illegal to plant GM crops within this zone. The Via Campesina and MST justified their occupation of Syngenta's site with Article 186 in the Brazilian constitution, which stipulates that private property (including land) must serve a social function. Since the early 1980s, the MST has used Article 186 to justify non-violent occupations of unproductive land owned by large landowners in order to pressure the government to expropriate the land for the purpose of agrarian reform. The movements argue that the land at Syngenta's experimental site, through the illegal cultivation of GM crops, was not serving its social function because it endangered Brazil's natural resource base, upon which all Brazilians depend. The occupation stopped all of Syngenta's activities at the site, and cost the multinational millions of dollars. Additionally, the occupation successfully pressured IBAMA to fine Syngenta US $462,000 (which remains unpaid), and applied continuous pressure on the governor to expropriate the site.

Nadal's article about Monsanto

Monsanto, Cereal Killer GM and Agrarian Suicides in India

by Alejandro Nadal ZNet, January 6 2007

http://www.zmag.org/content/showarticle.cfm?SectionID=66&ItemID=11790

[Alejandro Nadal is professor at the Center for Economic Studies and coordinator of the Science and Technology program of El Colegio de Mexico]

The Green Revolution is dead. Its hybrids and high-yield varieties allowed for significant increases in the production of crops like wheat. But its negative side effects have intensified rather than gone away.

The technological package of the Green Revolution caused severe salination of the soil, indiscriminate exploitation and choking of aquifers and intense pollution with all types of pesticides. More seriously, it sowed an economic, social and environmental crisis in the life of poor farmers that takes more lives every year. One example is that of Anil Khondwa Shinde, a small farmer of Vidarbha district in Maharashtra state (in mid-western India). He killed himself two months ago consuming a powerful insecticide. He was 31 years old and died within minutes. The difference between the production costs and the retail price did not allow him to pay back to the providers the credit extended to him for the inputs.

An isolated incident? Not at all. The Indian Ministry of Agriculture admits to the following figures: there were 100,000 suicides by farmers between 1993 and 2003. And between 2003 and October 2006, there have been some 16,000 suicides by farmers each year. In total, between 1993 and 2006, there were around 150,000 suicide by farmers, 30 a day for 13 years!

The Maharashtra government itself accepts the figure of 1,920 farmers' suicides in Vidarbha between January 2001 and August 2006. Farmers' organisations of the district state that there were 782 suicides by agricultural producers. Data for the past three months indicate that on average there was a suicide every eight hours.

What conditions give rise to a suicide rate of about 30 farmers a day? It is said that the reason for this is indebtedness, but the ultimate reason is the imposition of a completely unsuitable agricultural technology, as much from the economic as from the environmental viewpoint.

Anil Shinde had decided to plant Bt cotton, a transgenic variety produced by Monsanto that supposedly reduces the need for insecticides and increases the return for the grower. Shinde is not an exception. Hundreds of farmers who had planted transgenic cotton in the states of Maharashtra, Andhra Pradesh and Karnataka have sought suicide as way out of a desperate situation that worsens year after year.

An important element of the tale is that Monsanto's Bt cotton variety offers some protection against cotton bollworm (Helicoverpa zea) but not against other pests (Spodoptera, for example) which affect this commercial crop in India. Producers like Shinde, who turned to Monsanto cotton looking to lower pesticide costs, were taken by surprise though in any case, they have had to keep using the inputs. Even worse, the debt trap got on top of them much quicker as the Monsanto cotton seeds are more expensive.

In many districts, the local moneylenders of the past have been substituted by the network of dealers and salesmen of large companies and their methods of debt recovery have been frequently criticised. When the incidence of suicides intensified, the government launched a "help" programme with an assured payment of about $2,000 to the surviving families but that money goes straight to the pockets of the creditors and, in fact, has become a perverse incentive that more farmers take their lives.

But the politicians are the same on all sides. The Agriculture Minister, Sharad Pawar, delights in living in the past, always speaking about the triumph of the Green Revolution. The message of his speeches is always the same: India needs genetically modified crops to help the poor farmers escape poverty and to resolve the "problem of hunger".

Thanks to the neo-liberal opening-up promoted by the government, the area dedicated to transgenic cotton in Vidarbha increased from 0.4% to 15% in just three years. In that timeframe, the rate of agrarian suicides also increased, which makes Monsanto the worst serial killer in history. Or, if we want to play with words, just as that company plays with the life of millions of farmers, we could describe Monsanto as the worst cereal killer of the planet.

Thousands of farmers, whose way of life has been destroyed as they have fallen into the clutches of the creditors, have turned to suicide as the only escape. In the process, they have exposed the failure of an agricultural project based on a technological "solution" with multiple negative effects and dysfunctional social relations. Why not heal the damages of the Green Revolution rather than rush to embrace the GM technology?

The seeds of destruction want to tell us something. But this winter, New Delhi seems more concerned with environmental pollution than the tragedy that unfolds daily in the countryside.

Translated by Supriyo Chatterjee.

(Nadal's article, 'Monsanto y los suicidios agrarios en India', appeared in La Jornada, Mexico, on 26 December 2006.)

Supriyo Chatterjee: supriyo@chatterjees.freeserve.co.uk

from Pete Shanks

from Pete Shanks, author of Human Genetic Engineering: A Guide for Activists, Skeptics, and the Very Perplexed

Hi there

The Center for Genetics and Society (CGS) now has a blog, at http://www.biopoliticaltimes.org/, where various members of the CGS staff post and so occasionally do guests such as myself. The central topic is human biotech, but broader connections are often drawn. The intro is at http://www.biopoliticaltimes.org/2006/10/welcome.html.

I recently put up an item about the connections between the Food and Drug Administration (FDA) livestock-cloning report and the cloning companies and in turn their founders, who have human GE interests.

It's at http://www.biopoliticaltimes.org/2007/01/cloned-meat-hidden-
agendas-behind.html and also copied below, but without the links and formatting. [We've added some of the links below - ed]

It's public comment time at the FDA...

best
pete
---

Cloned Meat: the hidden agendas (behind the other hidden agendas)

posted by Pete Shanks

http://www.biopoliticaltimes.org/2007/01/cloned-meat-hidden-
agendas-behind.html

Who is pushing to legalize cloned meat? Follow the money -- and there are strong connections to human genetic engineering.

The Food and Drug Administration (FDA)'s draft risk assessment leans heavily on the work of animal-cloning companies Cyagra and ViaGen. Over a quarter of the 700-page draft is a data dump from those two -- a fact that the New York Times failed to mention, even when quoting the president of ViaGen saying "I think that this draft is going to provide the industry the comfort it needs."
http://www.fda.gov/cvm/CloneRiskAssessment.htm
http://www.nytimes.com/2006/12/28/business/28cnd-clone.html

ViaGen is part of the Exeter Life Science Group, owned by billionaire John Sperling, who also financed the notorious Genetic Savings and Clone (GSC). Viagen's chief scientist, Irina Polejaeva, was once GSC's, and when GSC closed ViaGen took over their gene banking operation. The cloned pets were rightly described by Wired as "a footnote to John Sperling's grand plan" -- and so are the cows and pigs. The plan is people -- living forever.
http://www.genetics-and-society.org/resources/items/20020429_
fortune_warner.html
http://www.wired.com/wired/archive/12.02/immortal.html

Cyagra was a subsidiary of Advanced Cell Technology (ACT), of press-release infamy. ACT sold Cyagra in one of its desperate grabs for cash, but chief scientist Robert Lanza and his former colleague Jose Cibelli (a co-author of Hwang Woo-suk's and a former consultant to the California stem cell institute -- it's a small universe) are cited throughout the FDA report.

The surface agenda the FDA addresses is public safety (though Stuart Newman [professor at New York Medical College] says "it's potentially a health hazard"); the agenda hidden in plain sight is that of commercial interests; and behind that lies the specter of human genetic engineering. It's a mutually reinforcing spiral: The animal cloners have been relying on human medical research (and of course feeding the starving) to make their work seem less unacceptable -- and the human cloners rely on the animal work to make theirs seem more reasonable.
http://www.thejournalnews.com/apps/pbcs.dll/article?AID=/
20070101/NEWS02/701010332/1018

The public does not want cloned meat and certainly wants it to be labeled, which the FDA says it cannot require. All the more reason to object now. The Center for Food Safety has been opposing animal cloning for years. So has the Organic Consumers Association, which has set up a handy site for responding to the FDA's call for public comment.
http://www.organicconsumers.org/rd/clones.htm

Reseña de "A Silent Forest"

http://www.freeradicals.org.uk/articles/book-and-film-reviews/a-silent-forest-40-27.html

A Silent Forest

WRITTEN BY SAM BURCHER

A film that exposes the growing global threat of genetically modified trees and the startling impact of genetic engineering on biodiversity

GM is science gone wrong

David Suzuki of David Suzuki Foundation is a geneticist who has enjoyed a twenty-five year career in science that includes heading the largest genetics laboratory in Canada. He agreed to narrate A Silent Forest because he is deeply concerned about the unseemly haste in applying ideas from genetic engineering to the real world. He believes that it is far too early to put genetically modified (GM) traits into medicines, and foods, or in our fields.

DNA taken from one species and inserted into another species, is horizontal gene transfer, and is the basis of genetic engineering. Suzuki is adamant that it is simply bad science for the pro-GM lobby to imply that horizontal gene transfer is the same process as the fundamental exchange of male and female genes, which is known as vertical inheritance.

"One gene, one protein, equals one trait"

This is the favoured theory used by genetic engineers to explain the process of artificial selection, and is, according to Suzuki, "a caricature of misrepresentation." In nature, genes function within the context of an entire genome, and within a whole organism. (See Living with the Fluid Genome http://www.i-s.org.uk/fluidGenome.php)

Genetic engineering alters the context in which the gene is found. It's new and complex, and yields unexplained results. Suzuki's example is to take the singer Bono out of his band U2, and putting him into the New York Philharmonic Orchestra. There would be sound, but there is no way of predicting how precise, or what the sum total of the activity would be.

Are GM trees real?

Genetically modified trees are not science fiction, Suzuki says. There are hundreds and possibly thousands of GM tree test plots all over the world. (See UN Caution Against GM trees, this issue). GM DNA is inserted into the embryos of plants usually using a bacterium or virus. These genes would be extracted from an unrelated organism, whose transfer could never happen naturally, or, by hybridisation.

The four design parameters of GM trees:

* Sterile trees - produce no nuts, fruits, seeds, flowers, or pollen. This drastic intervention, it is hoped, will stop the cross contamination of native trees and other species, via insects, and wind blown pollination.
* Herbicide resistant trees -can be sprayed with company herbicide and survive, but many other plants and species die.
* Low lignin trees -has had half it's strength removed. It grows faster, and is cheaper and easier for the paper industry to pulp. But it is vulnerable to environmental stresses such as high winds. Once fallen, it decomposes quicker, returning C02 to the atmosphere at an accelerated timescale.
* Total tree a pesticide - this tree is a systemic toxin that kills all insects that feed on it, with no specific target, and no limit as to what is harmed.

Environmental effects of GM trees

Sterility bred into plants and trees is no guarantee that cross-pollination stops happening. One hundred percent sterility is impossible, as the urge to reproduce is powerful. This technology can never be reliable; sterility can be spread into food crops and into native forests. Forests that cannot sustain insects and animals through its' harvest, are not forest at all.

Herbicide resistance is also problematic. The number one herbicide in the US is Monsanto's Roundup Ready. When liberally and/or aerially sprayed on GM crops and trees many plants in its path are killed, but so are earthworms and small mammals. Fish, frogs, and aquatic invertebrates are particularly sensitive to it. Roundup contains Glyphosate, a chemical known to cause birth defects and allergic effects (See Glyphosate toxic and Roundup worse (See http://www.i-sis.org.uk/GTARW.php)

In California, there has been an increase of illness in human outdoor workers who are using Roundup. Its effects on wildlife appear to be as lethal as DDT, which was considered an innovative chemical for pest control, until songbirds and eagles started to disappear. Denmark has had the foresight to ban glyphosate when it was found in drinking water.

Infecting the entire system of a tree with a toxin also harms many species. Monica Moore of PAN (Pesticide Action Network) points out that the pesticide gene is always "on" and expressing itself, and it cannot be turned off. She cautions that the insects that develop resistance to Bt, select similar insects, and produce superbugs. The film cites ISIS paper Superbugs and Anthrax genes, as a further warning of the potential hazards of Bt recombining with other bacteria genes in the soil.

What harm to humans and animals?

Dr Ignacio Chapela of Berkeley University says that Bt trees are a crazy idea. Trees have long life cycles, from between 50-100 years, and longer. Therefore putting toxins into every cell will affect insects and organisms for a very long time. Bt flows through the soil via the roots of GM trees (or GM corn) into the soil. This alters the microbial composition of the soil. From the soil it can leach into ground water and surface water. Where GM corn is grown, up to 5 times the safe limit of bt toxin is found in groundwater.

Dr Maewan Ho (ISIS), on her lecture tour of the Philippines at the end of 2005, found that farmers exposed to Bt crops in 2003 are still battling with illnesses. (See http://www.i-sis.org.uk/GMBanLongOverdue.php). Further illnesses in farm workers and handlers of Bt cotton, and mass deaths among sheep grazing in Bt cotton fields have now turned up in India.

Who owns life?

Percy Schmeiser features in the film and explains how Monsanto used him as a test case (Monsanto vs. Schmeiser), to gauge the legal implications of GM contamination. After two and a half weeks of trial, the judge ruled that it did not matter how GM particles got into his fields, e.g. by wind, buds, insects, passing truck. If even one percent of Schmiesers' crop was contaminated by GM material, then it becomes the property of the corporation.

The "one gene, one protein" hypothesis automatically assumes ownership on behalf of the corporation who has made the GM plant, tree, or seed, and whatever it comes into contact with and contaminates. One gene ownership is a dangerous premise with the potential to control our entire natural environment. This includes parks, and wildernesses, and represents the privitization of life itself. In theory pollen drift from a GM test plot in Michigan could contaminate all the trees in North America.

Impoverishing the global south
GM tree plantations are targeted at locations where labour and land is cheap. In countries such as Chile and Brazil an increasing amount of precious land and water is given over to GM plantations that destroy self-sufficient communities and ruin the lives of indigenous and rural people. (See "UN Caution over GM trees") No serious consideration is given to the effects of GM trees on communities or ecosystems.

Alternative methods of paper production must be developed in order to eliminate the need for forest-based paper manufacturing. There are many examples of strong natural crops such as hemp from which paper could be made. Ethical choices by consumers can influence industry in this direction. A great deal of savings on paper use in advertising and packaging can also be made.

David Suzuki concludes his narration by saying that most of our current ideas involving biotechnology are going to turn out to be wrong. In any revolutionary areas, many ideas are proved wrong, and this is how progress is made. The rush to commercialise GM trees is absolutely dangerous because we haven't a clue what the long-term implications of our manipulations will be.

For more details on protest days against GM trees, and to order a copy of A Silent Forest contact: www.globaljusticeecology.org

_______________________________
Info transferred via:

STOP Genetically Engineered Trees Campaign
http://www.stopgetrees.org
mailto:info@stopgetrees.org

A project of Global Justice Ecology Project
P.O. Box 412
Hinesburg, VT 05461 U.S.
+1.802.482.2689 ph/fax
mailto:info@globaljusticeecology.org
http://www.globaljusticeecology.org

QUEREMOS SOBERANÍA ALIMENTARIA, NO BIOCOMBUSTIBLES

Las organizaciones abajo firmantes manifestamos al Parlamento Europeo, la Comisión Europea, los gobiernos y ciudadanos de la Unión Europea, nuestra profunda preocupación por las políticas que se están adoptando para favorecer el uso e importación de biocombustibles como una alternativa a los combustibles fósiles cuyo uso desmedido es uno de los principales responsables del calentamiento global.

El incremento creciente de automóviles individuales, cuyo consumo de petróleo es una de las principales causas del calentamiento global, hace que el uso de combustible fósil aumente día a día. En ese contexto, el uso de biocombustibles parece ser una alternativa positiva. Sin embargo, todo indica que ello generará graves impactos, especialmente en los pueblos del Sur.

En efecto, es muy poco probable que Europa logre ser autosuficiente en la producción de biocombustibles a partir de la producción nacional de cultivos energéticos, por lo que es muy posible que lo haga a costa de las tierras de las que depende la soberanía alimentaria de nuestros países.

Mientras los europeos mantendrán su estilo de vida en base a la cultura del automóvil, los países del Sur, tendremos cada vez menos tierras para sembrar alimentos, y por lo mismo perderemos nuestra soberanía alimentaria y tendremos que basar nuestra alimentación en comida importada, posiblemente de Europa.

En otros casos, los cultivos energéticos crecerán en América Latina, como así también en países de Asia y Africa, a costa de nuestros ecosistemas naturales. La soya se proyecta como una de las principales fuentes para la producción de biodiesel, pero es un hecho que los monocultivos de soya son la principal causa de destrucción del bosque nativo en Argentina, del bosque húmedo tropical amazónico en Brasil y Bolivia, y de la Mata Atlántica en Brasil y Paraguay.

Los territorios indígenas también han sido afectados. Los indígenas Enawene Nawe en Matto Grosso han declarado que “la soya les está matando”. Al momento sobreviven apenas 429 Enawene Nawe. Su territorio ha sido reducido a la mitad y están rodeados por plantaciones de soya. Su salud está deteriorada y los niños sufren de desnutrición.

Para servir al negocio de la soya, los gobiernos del Sur están construyendo represas, hidrovías, puertos y carreteras, con los consiguientes graves impactos sobre el ambiente. Al mismo tiempo, la expansión de la soya está afectando la salud de las poblaciones aledañas, donde los niveles de cáncer y otras enfermedades ligadas a los agrotóxicos empleados en esos monocultivos aumentan cada vez más.

Las plantaciones de caña de azúcar y la producción de etanol en Brasil son el negocio de un oligopolio que utiliza trabajo esclavo y las plantaciones de palma aceitera se expanden a expensas de las selvas y territorios de poblaciones indígenas y otras comunidades tradicionales de Colombia, Ecuador y otros países, crecientemente orientados a la producción de biodiesel.

La situación se agrava si tomamos en cuenta que la soya sembrada en el Cono Sur es transgénica, y que empresas privadas en Brasil planean lanzar al mercado variedades transgénicas de caña de azúcar para el año 2010. El rechazo a los cultivos transgénicos es generalizado en América Latina, y la expansión de cultivos para producir y exportar biocombustibles a Europa exacerbará estos conflictos.

La solución al problema del cambio climático generado por los países del Norte no puede pasar por la creación de nuevos problemas en nuestra región. Hacemos entonces un llamado a los gobiernos y pueblos de los países de la Unión Europea para que busquen soluciones que no agraven la ya dramática situación social y ambiental que viven los pueblos de América Latina, Asia y Africa.

ES TIEMPO DE SOBERANÍA ALIMENTARIA

LA TIERRA DEBE SER PARA ALIMENTAR A LA GENTE, NO A LOS AUTOMÓVILES

Red por una América Latina Libre de Transgénicos, Red Latinoamericana contra los Monocultivos de Árboles, Red Oilwatch América del Sur, Movimiento Mundial por los Bosques Tropicales

Feliz año nuevo

GM WATCH COMMENT: Yesterday we brought you our choice of the best article of 2006 - Palagummi Sainath's powerful expose of the tragic consequences for farmers in Maharashtra of the gap between illusion and reality when it comes to Bt cotton.
http://www.gmwatch.org/archive2.asp?arcid=7430

Today we turn to our choice of the best report of 2006, which is:
Who benefits from GM crops?
Monsanto and the corporate-driven genetically modified crop revolution http://www.foei.org/publications/pdfs/gmcrops2006full.pdf

This report from Friends of the Earth International looks at the first 10 years of GM crops and systematically takes apart the hype and spin used by Monsanto and its supporters, showing how:

"The hype about the advantages that GM crops provide to the environment, consumers, and farmers is... predominantly the result of propaganda by the biotech industry and industry sponsored organizations including the International Service for the Acquisition of Agri-biotech Applications (ISAAA). ISAAA's annual reports, published at the beginning of every year since the late 1990s, have misrepresented the performance of GM crops. They have lauded the benefits that have accompanied the introduction of GM crops everywhere, and have ignored the negative impacts and other problems. In fact, as this report shows, the reality of GM crops has been strikingly different from Monsanto and ISAAA's claims."

Amongst much else, this report helps to explain the tragedy unfolding in places like Maharashtra:

"Ultimately, the story of the introduction of Bt cotton in India shows that when a big corporation decides to push a product, it will take extraordinary measures to conquer markets. The marketing blitz of seed companies like Mahyco-Monsanto has succeeded in convincing many farmers to switch over to Bt cotton, and such false promises and aggressive claims continue to this day."

As part of its exposure of the biotech industry's use of hype, "Who benefits from GM crops?" draws on two important earlier reports, and we have telling extracts from all three.

One of these reports is Aaron de Grassi's seminal 2003 analysis of the use of GM hype in Africa and beyond - "Genetically Modified Crops and Sustainable Poverty Alleviation in Sub-Saharan Africa; an assessment of current evidence".
http://allafrica.com/sustainable/resources/00010161.html

The other appeared just a few months before "Who benefits from GM crops?" It was a report based on research into how BT cotton was being marketed throughout India. These investigations were coordinated by the Centre for Sustainable Agriculture and Greenpeace India. "The Marketing of Bt Cotton in India" showed in startling detail how Monsanto's Indian subsidiary, Monsanto-Mahyco, and its sub-licensee Bt Cotton seed companies, had been pulling every dirty trick in the PR book in order to lure India's struggling farmers into using GM cotton.

We start with an extract from "Who benefits from GM crops?" The 75-page report looks at the gap between hype and reality right around the globe. The short extract we've chosen looks at Monsanto's unethical and irresponsible advertising campaigns and in particular its use of farmers as "the new biotech pawns". This leads on to extracts from the two earlier reports that add remarkable detail on the biotech industry's PR exploitation of farmers.

READ ON
---